<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Physiol</journal-id><journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id><journal-id journal-id-type="publisher-id">TJP</journal-id><journal-id journal-id-type="hwp">jphysiol</journal-id><journal-title-group><journal-title>The Journal of Physiology</journal-title></journal-title-group><issn pub-type="ppub">0022-3751</issn><issn pub-type="epub">1469-7793</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5509858</article-id><article-id pub-id-type="doi">10.1113/JP273142</article-id><article-id pub-id-type="publisher-id">TJP12403</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Cardiovascular</subject><subj-group subj-group-type="heading"><subject>Editor's Choice</subject></subj-group></subj-group></article-categories><title-group><article-title>A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal&#x02010;induced arrhythmias</article-title><alt-title alt-title-type="left-running-head">P.&#x02010;C. Yang and others</alt-title><alt-title alt-title-type="right-running-head">Sex&#x02010;based vulnerability to arousal arrhythmia</alt-title></title-group><contrib-group><contrib id="tjp12403-cr-0001" contrib-type="author"><name><surname>Yang</surname><given-names>Pei&#x02010;Chi</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="tjp12403-cr-0002" contrib-type="author"><name><surname>Perissinotti</surname><given-names>Laura L.</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="tjp12403-cr-0003" contrib-type="author"><name><surname>L&#x000f3;pez&#x02010;Redondo</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="tjp12403-cr-0004" contrib-type="author"><name><surname>Wang</surname><given-names>Yibo</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="tjp12403-cr-0005" contrib-type="author"><name><surname>DeMarco</surname><given-names>Kevin R.</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="tjp12403-cr-0006" contrib-type="author"><name><surname>Jeng</surname><given-names>Mao&#x02010;Tsuen</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="tjp12403-cr-0007" contrib-type="author"><name><surname>Vorobyov</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="tjp12403-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="tjp12403-cr-0008" contrib-type="author" corresp="yes"><name><surname>Harvey</surname><given-names>Robert D.</given-names></name><address><email>rdharvey@medicine.nevada.edu</email></address><xref ref-type="aff" rid="tjp12403-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="tjp12403-cr-0009" contrib-type="author"><name><surname>Kurokawa</surname><given-names>Junko</given-names></name><address><email>junkokuro@u-shizuoka-ken.ac.jp</email></address><xref ref-type="aff" rid="tjp12403-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="tjp12403-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="tjp12403-cr-0010" contrib-type="author" corresp="yes"><name><surname>Noskov</surname><given-names>Sergei Y.</given-names></name><address><email>snoskov@ucalgary.ca</email></address><xref ref-type="aff" rid="tjp12403-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="tjp12403-cr-0011" contrib-type="author" corresp="yes"><name><surname>Clancy</surname><given-names>Colleen E.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6849-4885</contrib-id><address><email>ceclancy@ucdavis.edu</email></address><xref ref-type="aff" rid="tjp12403-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="tjp12403-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pharmacology, School of Medicine</named-content>
<institution>University of California</institution>
<named-content content-type="city">Davis</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff><aff id="tjp12403-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Centre for Molecular Simulation, Department of Biological Sciences</named-content>
<institution>University of Calgary</institution>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="tjp12403-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Bio&#x02010;informational Pharmacology, Medical Research Institute</named-content>
<institution>Tokyo Medical and Dental University</institution>
</aff><aff id="tjp12403-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Pharmacology</named-content>
<institution>University of Nevada</institution>
<named-content content-type="city">Reno</named-content>
<named-content content-type="country-part">NV</named-content>
<country country="US">USA</country>
</aff><aff id="tjp12403-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Bio&#x02010;informational Pharmacology, School of Pharmaceutical Sciences</named-content>
<institution>University of Shizuoka</institution>
<named-content content-type="city">Shizuoka</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Corresponding authors</bold> C. E. Clancy: Department of Pharmacology, University of California, Davis, Genome Building Rm 3503, Davis, CA, 95616&#x02013;8636, USA. Email:&#x000a0;<email>ceclancy@ucdavis.edu</email>; S. Noskov: Centre for Molecular Simulation, Department of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, T2N 1N4, Canada. Email:&#x000a0;<email>snoskov@ucalgary.ca</email>; J. Kurokawa: Department of Bio&#x02010;informational Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, 422&#x02010;8002, Japan. Email:&#x000a0;<email>junkokuro@u-shizuoka-ken.ac.jp</email>; R. D. Harvey: Department of Pharmacology, University of Nevada, Reno, Center for Molecular Medicine &#x02013; MS 573, School of Medicine, Reno, NV, 89557, USA, Email:&#x000a0;<email>rdharvey@medicine.nevada.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>6</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>595</volume><issue>14</issue><issue-id pub-id-type="doi">10.1113/tjp.2017.595.issue-14</issue-id><fpage>4695</fpage><lpage>4723</lpage><history><date date-type="received"><day>20</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2017 The Physiological Society <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. The Journal of Physiology published by John Wiley &#x00026; Sons Ltd on behalf of The Physiological Society</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:TJP-595-4695.pdf"/><abstract><sec id="tjp12403-sec-0010"><title>Key points</title><p>
<list list-type="bullet" id="tjp12403-list-0001"><list-item><p>This study represents a first step toward predicting mechanisms of sex&#x02010;based arrhythmias that may lead to important developments in risk stratification and may inform future drug design and screening.</p></list-item><list-item><p>We undertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation) required for triggering and sustaining reentrant arrhythmias.</p></list-item><list-item><p>Using the recently solved cryo&#x02010;EM structure for the Eag&#x02010;family channel as a template, we revealed potential interactions of oestrogen with the pore loop hERG mutation (G604S).</p></list-item><list-item><p>Molecular models suggest that oestrogen and dofetilide blockade can concur simultaneously in the hERG channel pore.</p></list-item></list>
</p></sec><sec id="tjp12403-sec-0020"><title>Abstract</title><p>Female sex is a risk factor for inherited and acquired long&#x02010;QT associated torsade de pointes (TdP) arrhythmias, and sympathetic discharge is a major factor in triggering TdP in female long&#x02010;QT syndrome patients. We used a combined experimental and computational approach to predict &#x02018;the perfect storm&#x02019; of hormone concentration, <italic>I</italic>
<sub>Kr</sub> block and sympathetic stimulation that induces arrhythmia in females with inherited and acquired long&#x02010;QT. More specifically, we developed mathematical models of acquired and inherited long&#x02010;QT syndrome in male and female ventricular human myocytes by combining effects of a hormone and a hERG blocker, dofetilide, or hERG mutations. These &#x02018;male&#x02019; and &#x02018;female&#x02019; model myocytes and tissues then were used to predict how various sex&#x02010;based differences underlie arrhythmia risk in the setting of acute sympathetic nervous system discharge. The model predicted increased risk for arrhythmia in females when acute sympathetic nervous system discharge was applied in the settings of both inherited and acquired long&#x02010;QT syndrome. Females were predicted to have protection from arrhythmia induction when progesterone is high. Males were protected by the presence of testosterone. Structural modelling points towards two plausible and distinct mechanisms of oestrogen action enhancing torsadogenic effects: oestradiol interaction with hERG mutations in the pore loop containing G604 or with common TdP&#x02010;related blockers in the intra&#x02010;cavity binding site. Our study presents findings that constitute the first evidence linking structure to function mechanisms underlying female dominance of arousal&#x02010;induced arrhythmias.</p></sec></abstract><abstract id="d35e381" abstract-type="toc"><title>Key points</title><p>
<list list-type="bullet" id="tjp12403-list-0002"><list-item><p>This study represents a first step toward predicting mechanisms of sex&#x02010;based arrhythmias that may lead to important developments in risk stratification and may inform future drug design and screening.</p></list-item><list-item><p>We undertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation) required for triggering and sustaining reentrant arrhythmias.</p></list-item><list-item><p>Using the recently solved cryo&#x02010;EM structure for the Eag&#x02010;family channel as a template, we revealed potential interactions of oestrogen with the pore loop hERG mutation (G604S).</p></list-item><list-item><p>Molecular models suggest that oestrogen and dofetilide blockade can concur simultaneously in the hERG channel pore.</p></list-item></list>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="tjp12403-kwd-0001">arrhythmias</kwd><kwd id="tjp12403-kwd-0002">computational model</kwd><kwd id="tjp12403-kwd-0003">dofetilide</kwd><kwd id="tjp12403-kwd-0004">hERG mutation</kwd><kwd id="tjp12403-kwd-0005">long&#x02010;QT</kwd><kwd id="tjp12403-kwd-0006">sex&#x02010;differences</kwd><kwd id="tjp12403-kwd-0007">TdP</kwd></kwd-group><funding-group><award-group><funding-source>MEXT/JSPS</funding-source><award-id>KAKENHI 15H04684</award-id></award-group></funding-group><funding-group><award-group><funding-source>Japan AMED</funding-source><award-id>16mk0104027h1102</award-id><award-id>16mk0104007h9903</award-id></award-group></funding-group><funding-group><award-group><funding-source>American Heart Association Predoctoral Fellowship</funding-source><award-id>16PRE27260295</award-id></award-group></funding-group><funding-group><award-group><funding-source>Canadian Institutes of Health Research</funding-source><award-id>MOP&#x02010;186232</award-id></award-group></funding-group><funding-group><award-group><funding-source>National Institutes of Health</funding-source><award-id>R01HL128537&#x02010;01A1</award-id><award-id>NHLBI R01HL128170&#x02010;02</award-id><award-id>NHLBI 1U01HL126273&#x02010;02</award-id><award-id>R01GM10192801</award-id><award-id>R01GM10192801</award-id><award-id>NHLBI U01HL126273&#x02010;02</award-id><award-id>R0HL12853701A1</award-id></award-group></funding-group><funding-group><award-group><funding-source>American Heart Association</funding-source><award-id>13GRNT14370019</award-id></award-group></funding-group><counts><fig-count count="16"/><table-count count="7"/><page-count count="29"/><word-count count="15561"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>tjp12403</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>15 July 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.4 mode:remove_FC converted:13.07.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="tjp12403-note-0001"><p>This is an Editor's Choice article from the 15 July 2017 issue.</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="tjp12403-lp-0001"><title>Abbreviations</title><def-item><term>APD</term><def><p>action potential duration</p></def></def-item><def-item><term>BCL</term><def><p>basic cycle length</p></def></def-item><def-item><term>DHT</term><def><p>dihydrotestosterone
</p></def></def-item><def-item><term>E2</term><def><p>oestradiol</p></def></def-item><def-item><term>EAD</term><def><p>early afterdepolarization
</p></def></def-item><def-item><term>hERG</term><def><p>human <italic>ether&#x02010;&#x000e0;&#x02010;go&#x02010;go</italic>&#x02010;related gene
</p></def></def-item><def-item><term><italic>I</italic><sub>Ks</sub></term><def><p>slow delayed rectifier K<sup>+</sup> current</p></def></def-item><def-item><term><italic>I</italic><sub>Ca&#x02010;L</sub></term><def><p>inward Ca<sup>2+</sup> current,</p></def></def-item><def-item><term>ISO</term><def><p>isoproterenol</p></def></def-item><def-item><term>MD</term><def><p>molecular dynamics</p></def></def-item><def-item><term>OA</term><def><p>okadaic acid</p></def></def-item><def-item><term>Pg</term><def><p>progesterone</p></def></def-item><def-item><term>PKA</term><def><p>protein kinase A
</p></def></def-item><def-item><term>QTc</term><def><p>corrected QT</p></def></def-item><def-item><term>SNS</term><def><p>sympathetic nervous system</p></def></def-item><def-item><term>TdP</term><def><p>torsade de pointes</p></def></def-item></def-list><sec id="tjp12403-sec-0030"><title>Introduction</title><p>Cardiac arrhythmia is a primary cause of mortality in both males and females, but the risk factors associated with some types of arrhythmias differ between the sexes. Female sex is the dominant risk factor for acquired long&#x02010;QT&#x02010;dependent arrhythmias after puberty, with at least 70% incidence in females (Makkar <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0062" ref-type="ref">1993</xref>). Despite recognition of this fact, the specific mechanisms underlying sex&#x02010;based differences in humans are notably understudied and have not been comprehensively revealed (Tadros <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0093" ref-type="ref">2014</xref>; Salama &#x00026; Bett, <xref rid="tjp12403-bib-0085" ref-type="ref">2014</xref>). Clinical and experimental data uniformly agree that women have longer QT intervals than men and are more likely to develop long&#x02010;QT&#x02010;dependent arrhythmias such as torsade de pointes (TdP) (Lehmann <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0055" ref-type="ref">1996</xref>; Pham <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0079" ref-type="ref">2001</xref>; Rodriguez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0082" ref-type="ref">2001</xref>; Pham <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0077" ref-type="ref">2002</xref>; Salama &#x00026; Bett, <xref rid="tjp12403-bib-0085" ref-type="ref">2014</xref>) that can degenerate into sudden cardiac death. Women are also susceptible to <italic>acquired</italic> long&#x02010;QT syndrome, resulting from block of the cardiac repolarizing rapidly activating delayed rectifier K<sup>+</sup> current (<italic>I</italic>
<sub>Kr</sub>), through the human <italic>ether&#x02010;&#x000e0;&#x02010;go&#x02010;go</italic>&#x02010;related gene (hERG) channel arising from the <italic>KCNH2</italic> gene.</p><p>The longer QT interval observed in women is attributed to a reduced repolarization reserve (James <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0041" ref-type="ref">2007</xref>). Recent clinical and experimental studies suggest that this is due to the non&#x02010;genomic effects that sex steroid hormones have on the electrical properties of the heart (Burke <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0010" ref-type="ref">1997</xref>; Rodriguez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0082" ref-type="ref">2001</xref>; Bai <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0003" ref-type="ref">2005</xref>; Liu <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0057" ref-type="ref">2005</xref>; Nakagawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0067" ref-type="ref">2006</xref>; Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>; Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>, <xref rid="tjp12403-bib-0050" ref-type="ref">2009</xref>; Sims <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0087" ref-type="ref">2008</xref>; Yang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0104" ref-type="ref">2012</xref>; Salama &#x00026; Bett, <xref rid="tjp12403-bib-0085" ref-type="ref">2014</xref>; Anneken <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0001" ref-type="ref">2016</xref>). Oestrogen and progesterone interact acutely with multiple subcellular targets, altering the resultant emergent electrical activity at the level of cells and tissues (Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>; Yang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0103" ref-type="ref">2010</xref>; Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0049" ref-type="ref">2015</xref>). During the menstrual follicular phase (prior to ovulation), oestrogen level is the highest, QT interval is longer and susceptibility to drug&#x02010;induced arrhythmias is increased. In the luteal phase (following ovulation) progesterone is increased and arrhythmic events associated with acquired and inherited long&#x02010;QT syndrome are reduced (Burke <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0010" ref-type="ref">1997</xref>; Rodriguez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0082" ref-type="ref">2001</xref>; Nakagawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0067" ref-type="ref">2006</xref>; Anneken <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0001" ref-type="ref">2016</xref>).</p><p>The differences in arrhythmia vulnerability during discrete stages of the menstrual cycle are likely to reflect the effects that sex steroid hormones have on cardiac ion channels (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>; Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0050" ref-type="ref">2009</xref>). Oestradiol (E2) has been shown to inhibit <italic>I</italic>
<sub>Kr</sub>, although the specific interaction sites have not been fully identified (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>). The result of E2 interaction with hERG is an increase in ventricular action potential duration, consistent with the longer QT interval observed in women during the follicular phase of the menstrual cycle. Progesterone, on the other hand, enhances the slow delayed rectifier K<sup>+</sup> current (<italic>I</italic>
<sub>Ks</sub>), generated by the KvLQT1 channel (encoded by the <italic>KCNQ1</italic> gene), through a nitric oxide&#x02010;dependent signalling pathway. This causes a decrease in ventricular action potential duration, consistent with the shorter QT interval observed during the luteal phase prolongation (Nakagawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0067" ref-type="ref">2006</xref>). The effect of progesterone is similar to the effect of the male sex hormone testosterone, which not only enhances <italic>I</italic>
<sub>Ks</sub> via a NO&#x02010;dependent mechanism, but also inhibits the inward Ca<sup>2+</sup> current (I<sub>Ca&#x02010;L</sub>), both of which contribute to a shortening of the ventricular action potential and the QT interval in males after puberty (Bai <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0003" ref-type="ref">2005</xref>).</p><p>There are also sex&#x02010;based differences in the effects of the autonomic nervous system. Increased sympathetic or decreased parasympathetic stimulation produces a rate&#x02010;dependent decrease in ventricular action potential duration (APD), but this effect is greater in men than in women (Magnano <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0061" ref-type="ref">2002</xref>; Nakagawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0066" ref-type="ref">2005</xref>; Hoeker <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0036" ref-type="ref">2014</xref>). This correlates with a longer rate&#x02010;corrected QT (QTc) interval in women. Changes in the balance of sympathetic and parasympathetic tone contribute to many types of arrhythmias often resulting in sudden cardiac death (Lanfranchi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0052" ref-type="ref">2010</xref>).</p><p>Long&#x02010;QT syndrome type 2 patients are susceptible to sudden arousal associated with loud noise or emotional stress (Moss <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0064" ref-type="ref">1999</xref>; Wilde <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0100" ref-type="ref">1999</xref>). A recent population study noted that 82% of the observed arousal&#x02010;induced arrhythmias occurred in females (Kim <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0046" ref-type="ref">2010</xref>). In order to begin to understand why changes in autonomic tone are more likely to contribute to arousal&#x02010;induced arrhythmias in females, we utilized computer models from our previous work that were based on and validated by experimental data to reflect acute actions of physiologically relevant human concentrations of sex steroid hormones progesterone, oestrogen and testosterone (Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>; Yang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0103" ref-type="ref">2010</xref>; Yang &#x00026; Clancy, <xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>). Here, we extended and expanded those models, and undertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation) required for triggering and sustaining reentrant arrhythmias in females in the setting of acute sympathetic arousal. We also employed a protein structure&#x02010;based molecular docking approach to explore the possible interactions between oestrogen, hERG mutations and hERG blocking drugs like dofetilide. Like the hERG blocker ibutilide, which exhibits clear sex&#x02010; and menstrual cycle&#x02010;dependent effects (Rodriguez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0082" ref-type="ref">2001</xref>), Pham &#x00026; Rosen (<xref rid="tjp12403-bib-0078" ref-type="ref">2002</xref>) reported that submicromolar concentrations of dofetilide coupled with physiological oestrogen levels produced a substantial APD<sub>90</sub> increase in females compared to males.</p><p>The results of this study suggest that specific therapeutic anti&#x02010;arrhythmic strategies for women with long&#x02010;QT syndrome should be studied. The study also suggests molecular determinants of drugs that might be especially problematic in females. These predictions might inform future drug design and screening.</p></sec><sec id="tjp12403-sec-0040"><title>Methods</title><sec id="tjp12403-sec-0050"><title>Ethics approval</title><p>Animal use was approved by the Institutional Animal Care and Use Committee of Tokyo Medical and Dental University, and conformed to the principles and standards for reporting animal experiments in <italic>The Journal of Physiology</italic> and <italic>Experimental Physiology</italic> (Grundy, <xref rid="tjp12403-bib-0034" ref-type="ref">2015</xref>).</p><p>For Fig.&#x000a0;<xref rid="tjp12403-fig-0001" ref-type="fig">1</xref> and Tables&#x000a0;<xref rid="tjp12403-tbl-0001" ref-type="table-wrap">1</xref> and <xref rid="tjp12403-tbl-0002" ref-type="table-wrap">2</xref>, experimental methods have been reported following the MICEE reporting standard (see <ext-link ext-link-type="uri" xlink:href="http://www.micee.org">www.micee.org</ext-link>): type: isolated cardiac ventricular myocytes; sex: male; weight: 251&#x02013;350&#x000a0;g; species: Hartley guinea pig; supplier: Saitama Experimental Animal Supply Co. Ltd (Saitama, Japan).</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Simulated and experimentally recorded <italic>I</italic>
<sub>caL</sub> data under ISO stimulations</title><p>
<italic>A</italic>, effect of DHT (100&#x000a0;n<sc>m</sc>) on <italic>I&#x02013;V</italic> curves from guinea pig ventricular myocytes (<italic>n</italic>&#x000a0;=&#x000a0;5). <italic>B</italic>, experimental data (error bars indicated by red, <italic>n</italic>&#x000a0;=&#x000a0;5 for each case) compared to simulated relative changes of the peak <italic>I</italic>
<sub>CaL</sub> to ISO application.</p></caption><graphic id="nlm-graphic-1" xlink:href="TJP-595-4695-g001"/></fig><table-wrap id="tjp12403-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Experimental data for effects of testosterone on <italic>I</italic>
<sub>Ca,L</sub> for males</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="plusmn" span="1"/><col align="char" char="plusmn" span="1"/><col align="char" char="plusmn" span="1"/><col align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Isoproterenol</th><th align="center" rowspan="1" colspan="1">
<italic>I</italic>
<sub>max</sub> (pA&#x000a0;pF<sup>&#x02212;1</sup>)</th><th align="center" rowspan="1" colspan="1">
<italic>V</italic>
<sub>1/2</sub> (mV)</th><th align="center" rowspan="1" colspan="1">
<italic>K</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>n</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Activation</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ISO</td><td align="char" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212;24.7&#x000a0;+&#x000a0;1.9</td><td align="center" rowspan="1" colspan="1">4.9&#x000a0;+&#x000a0;0.5</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ISO&#x000a0;+&#x000a0;100&#x000a0;n<sc>m</sc> DHT</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">&#x02212;19.7&#x000a0;&#x000b1;&#x000a0;2.1</td><td align="char" rowspan="1" colspan="1">5.3&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Inactivation</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ISO</td><td align="char" rowspan="1" colspan="1">&#x02212;27.0&#x000a0;&#x000b1;&#x000a0;3.6</td><td align="char" rowspan="1" colspan="1">&#x02212;26.8&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="char" rowspan="1" colspan="1">6.3&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ISO&#x000a0;+&#x000a0;100&#x000a0;n<sc>m</sc> DHT</td><td align="char" rowspan="1" colspan="1">&#x02212;19.9&#x000a0;&#x000b1;&#x000a0;4.5</td><td align="char" rowspan="1" colspan="1">&#x02212;28.9&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="char" rowspan="1" colspan="1">6.0&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap id="tjp12403-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Experimental data for effects of DHT with cAMP&#x000a0;+&#x000a0;OA on <italic>I</italic>
<sub>Ca,L</sub> current amplitude</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th colspan="3" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Normalized peak <italic>I</italic>
<sub>CaL</sub>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">DHT concentration</th><th align="center" rowspan="1" colspan="1">Mean (%)</th><th align="center" rowspan="1" colspan="1">SEM</th><th align="left" rowspan="1" colspan="1">
<italic>n</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">100&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">85.6</td><td align="char" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">30&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">81.3</td><td align="char" rowspan="1" colspan="1">10.6</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">10&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">86.7</td><td align="char" rowspan="1" colspan="1">8.3</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">1&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">98.8</td><td align="char" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><sec id="tjp12403-sec-0060"><title>Isolation procedure</title><p>Adult guinea pigs (white Hartley; 251&#x02013;350&#x000a0;g) were deeply anaesthetized with intra&#x02010;peritoneal injection of sodium pentobarbital (50&#x000a0;mg&#x000a0;g<sup>&#x02212;1</sup>, <sc>i</sc>.<sc>p.</sc>), and then killed by cervical dislocation. Hearts were perfused via the aorta with warm (36&#x000a0;&#x000b1;&#x000a0;1&#x000b0;C) and oxygenated solutions as follows: (1) Tyrode solution containing (in mmol&#x000a0;l<sup>&#x02212;1</sup>): 135 NaCl, 5.4 KCl, 1.8 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 glucose and 10&#x000a0;Hepes, pH&#x000a0;7.4, for 5&#x000a0;min; (2) Ca<sup>2+</sup>&#x02010;free Tyrode solution removing CaCl<sub>2</sub> from the Tyrode solution; (3) Ca<sup>2+</sup>&#x02010;free Tyrode solution containing collagenase (120&#x000a0;units&#x000a0;ml<sup>&#x02212;1</sup>) and albumin (1&#x000a0;mg&#x000a0;ml<sup>&#x02212;1</sup>), for 18&#x000a0;min; and (4) low&#x02010;Ca<sup>2+</sup> Tyrode solution with 0.2&#x000a0;mmol&#x000a0;l<sup>&#x02212;1</sup> CaCl<sub>2</sub>, for 5&#x000a0;min. At the end of the perfusion, the ventricles were minced in No. 4 solution to release single cells. Only the quiescent myocytes with clear striations were used for this study.</p></sec><sec id="tjp12403-sec-0070"><title>Electrophysiological recordings</title><p>For Fig.&#x000a0;<xref rid="tjp12403-fig-0001" ref-type="fig">1</xref>. L&#x02010;type Ca<sup>2+</sup> channel currents (<italic>I</italic>
<sub>Ca,L</sub>) were recorded with the whole&#x02010;cell configuration of the patch&#x02010;clamp technique with an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Signals were low&#x02010;pass filtered at 5&#x000a0;kHz, sampled at 5&#x000a0;kHz, and compensated for cell capacitance (no series resistance compensation). The pCLAMP software (version 9.0, Molecular Devices) was used to generate voltage&#x02010;pulse protocols, and for acquisition and analysis of data. The series resistance was 7.2&#x000a0;&#x000b1;&#x000a0;0.6&#x000a0;M&#x003a9;, the capacitance time constant was 2.2&#x000a0;&#x000b1;&#x000a0;0.3&#x000a0;ms, and the membrane capacitance was 139.3&#x000a0;&#x000b1;&#x000a0;7.4&#x000a0;pF (<italic>n</italic>&#x000a0;=&#x000a0;22). All experiments were performed at 36&#x000a0;&#x000b1;&#x000a0;1&#x000b0;C. Pipette solution contained (in mmol&#x000a0;l<sup>&#x02212;1</sup>): 130 CsCl, 2 MgCl<sub>2</sub>, 5 adenosine&#x02010;5&#x02032;&#x02010;triphosphate disodium salt, 10&#x000a0;Hepes, 20 TEA&#x02010;Cl, 10 EGTA (pH&#x000a0;7.25 adjusted with CsOH). External (bath) solution contained (in mmol&#x000a0;l<sup>&#x02212;1</sup>): 135 NaCl, 5.4 CsCl, 0.53 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 5.5 glucose and 5&#x000a0;Hepes (pH&#x000a0;7.4 adjusted with CsOH).</p><p>Effects of dihydrotestosterone (DHT) were obtained under sympathetic nervous system (SNS) activation by 10&#x000a0;min dialysis of 3&#x02032;,5&#x02032;&#x02010;cyclic adenosine monophosphate (cAMP; 0.2&#x000a0;mmol&#x000a0;l<sup>&#x02212;1</sup>) and okadaic acid (OA; 0.2&#x000a0;&#x003bc;mol&#x000a0;l<sup>&#x02212;1</sup>) or by 3&#x000a0;min external application of (&#x02212;)&#x02010;isoproterenol (ISO) hydrochloride (0.1&#x000a0;&#x003bc;mol&#x000a0;l<sup>&#x02212;1</sup>).</p><p>To monitor peak inward <italic>I</italic>
<sub>Ca,L</sub>, a pre&#x02010;pulse (100&#x000a0;ms) was applied to &#x02013;40&#x000a0;mV from a <italic>V</italic>
<sub>h</sub> of &#x02013;80&#x000a0;mV to inactivate the Na<sup>+</sup> channels and the T&#x02010;type Ca<sup>2+</sup> channels, followed by a 200&#x000a0;ms <italic>V</italic>
<sub>t</sub> change to 0&#x000a0;mV at 1&#x000a0;Hz. To obtain <italic>I&#x02013;V</italic> relationships for measurement of <italic>I</italic>
<sub>Ca,L</sub> activation, <italic>V</italic>
<sub>t</sub> was changed from &#x02212;60&#x000a0;mV to 50&#x000a0;mV in 10&#x000a0;mV increments. To generate steady state inactivation curves, long pre&#x02010;pulses (500&#x000a0;ms) to different voltages (&#x02212;50 to 20&#x000a0;mV) were applied to allow inactivation to reach a steady state. Then the voltage was set to &#x02212;40&#x000a0;mV for 10&#x000a0;ms to close the channels, after which a <italic>V</italic>
<sub>t</sub> change to 10&#x000a0;mV for 200&#x000a0;ms was applied to assess the state of inactivation of the channels.</p></sec><sec id="tjp12403-sec-0080"><title>Model development</title><p>We recently developed &#x02018;male&#x02019; and &#x02018;female&#x02019; computational model representations of human ventricular cardiac myocytes that include genomic&#x02010;based differences in expression of key cardiac channels with human physiological concentrations of sex hormones on human action potentials (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>; Yang &#x00026; Clancy, <xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>). The genomic differences were based on measured expression levels of key cardiac ion channel genes as well as connexin43 (underlying the dominant gap&#x02010;junction subunit) in epicardial and endocardial ventricular tissue from non&#x02010;diseased explanted male and female human hearts (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0030" ref-type="ref">2010</xref>). We utilized these data (in construction of &#x02018;male&#x02019; and &#x02018;female&#x02019; human heart cell computational models by scaling the conductances of the corresponding currents in the O'Hara&#x02013;Rudy human ventricular cell model (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>) as described in Yang &#x00026; Clancy (<xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>) (see also Appendix Table <xref rid="tjp12403-tbl-0006" ref-type="table-wrap">A1</xref>). Included in the male model based on new data (shown in Tables&#x000a0;<xref rid="tjp12403-tbl-0001" ref-type="table-wrap">1</xref> and <xref rid="tjp12403-tbl-0002" ref-type="table-wrap">2</xref> and Fig.&#x000a0;<xref rid="tjp12403-fig-0001" ref-type="fig">1</xref>) is the effect of the acute application of a physiological concentration of testosterone (dihydrotestosterone, DHT) 35&#x000a0;n<sc>m</sc>, reflecting normal high ranges in post&#x02010;pubescent pre&#x02010;senescent males (Dorgan <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0017" ref-type="ref">2002</xref>).</p></sec></sec><sec id="tjp12403-sec-0090"><title>Simulation of acute sex steroid hormone effects</title><p>Three distinct female models were developed that include the hormones 17&#x003b2;&#x02010;oestradiol (E2) (Munro <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0065" ref-type="ref">1991</xref>; Dighe <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0016" ref-type="ref">2005</xref>) and progesterone (Pg) (Munro <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0065" ref-type="ref">1991</xref>; Janse de Jonge <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0042" ref-type="ref">2001</xref>) during the early follicular, late follicular and luteal phases of the menstrual cycle. The hormone concentrations used in the model simulations and their specific sources are as shown in Table <xref rid="tjp12403-tbl-0003" ref-type="table-wrap">3</xref>.</p><table-wrap id="tjp12403-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>The female hormone concentrations used in the computational model</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Menstrual cycle</th><th align="center" rowspan="1" colspan="1">17&#x003b2;&#x02010;Oestradiol</th><th align="center" rowspan="1" colspan="1">Progesterone</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Early follicular stage</td><td align="char" rowspan="1" colspan="1">0.1&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">2.5&#x000a0;n<sc>m</sc>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Late follicular stage</td><td align="char" rowspan="1" colspan="1">1.0&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">2.5&#x000a0;n<sc>m</sc>&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Luteal stage</td><td align="char" rowspan="1" colspan="1">0.7&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">40.6&#x000a0;n<sc>m</sc>&#x000a0;</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>The E2 reference ranges are from Munro <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0065" ref-type="ref">1991</xref>) and Dighe <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0016" ref-type="ref">2005</xref>). The Pg reference ranges (used in our initial study; Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>) are from Janse de Jonge <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0042" ref-type="ref">2001</xref>) and Munro <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0065" ref-type="ref">1991</xref>).</p></sec><sec id="tjp12403-sec-0100"><title>Simulating the effects of dofetilide</title><p>An <italic>I</italic>
<sub>Kr</sub> Markov model (Romero <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0084" ref-type="ref">2014</xref>) was incorporated into the O'Hara&#x02013;Rudy human ventricular action potential (AP) model (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>) to simulate the effects of dofetilide on <italic>I</italic>
<sub>Kr</sub>.</p></sec><sec id="tjp12403-sec-0110"><title>Simulated G604S mutation</title><p>Experiments suggest that the G604S hERG pore loop mutation alters the current amplitude and the gating of the wild&#x02010;type (WT) hERG channel. We simulated the mutant <italic>I</italic>
<sub>Kr</sub> (heterozygous channel:&#x000a0;50% each of WT and G604S) by modifying the conductance of WT current and also the kinetics of WT channel from the O'Hara&#x02013;Rudy human model (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>) based on the experimental data shown in Table&#x000a0;<xref rid="tjp12403-tbl-0004" ref-type="table-wrap">4</xref>.</p><table-wrap id="tjp12403-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>G604S mutant values</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">Mutation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>G</italic>
<sub>Kr</sub>
</td><td align="center" rowspan="1" colspan="1">0.046</td><td align="center" rowspan="1" colspan="1">0.0147</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>kr</sub>
</td><td align="center" rowspan="1" colspan="1">1.0/{1.0&#x000a0;+&#x000a0;exp[(<italic>v</italic>&#x000a0;+&#x000a0;55.0)/75.0]}&#x000a0;&#x000d7; 1.0/{1.0&#x000a0;+ exp[(<italic>v</italic>&#x000a0;&#x02212; 10.0)/30.0]}</td><td align="center" rowspan="1" colspan="1">1.0/{1.0&#x000a0;+&#x000a0;exp[(<italic>v</italic>&#x000a0;+&#x000a0;55.0&#x000a0;+ 9)/75.0]} &#x000d7; 1.0/{1.0&#x000a0;+ exp[(<italic>v</italic>&#x000a0;&#x02212; 10.0)/30.0]}</td></tr><tr><td align="left" rowspan="1" colspan="1">Reference</td><td align="center" rowspan="1" colspan="1">O'Hara <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>)</td><td align="center" rowspan="1" colspan="1">Huo <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0039" ref-type="ref">2008</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tjp12403-tbl4-note-0001"><p>
<italic>v</italic> is membrane potential (mV).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="tjp12403-sec-0120"><title>Simulation of sympathetic nervous system: protein kinase A effects</title><p>We simulated the effects of 1&#x000a0;&#x003bc;<sc>m</sc> ISO on <italic>I</italic>
<sub>caL</sub>, <italic>I</italic>
<sub>ks</sub>, <italic>I</italic>
<sub>kb</sub>, <italic>I</italic>
<sub>Na</sub>, <italic>J</italic>
<sub>rel</sub>, <italic>J</italic>
<sub>up</sub>, troponin and <italic>I</italic>
<sub>Nak</sub>, according to O'Hara &#x00026; Rudy (<xref rid="tjp12403-bib-0072" ref-type="ref">2012</xref>). In addition, progesterone and testosterone affect the conductance of <italic>I</italic>
<sub>Ks</sub>, but have no distinguishable effects on its kinetics under SNS stimulations. To model the effects of progesterone and testosterone on <italic>I</italic>
<sub>Ks</sub>, we modified <italic>G</italic>
<sub>Ks</sub> by scaling factors as indicated by the experimental data. In order to not overestimate the combined effects of DHT and SNS on <italic>I</italic>
<sub>Ks</sub>, we assumed that the combined effects reached a saturating level that is less than an additive effect, as was shown for progesterone. If the combination were additive, we would expect even more protection by testosterone in the setting of SNS.</p><p>Testosterone and SNS stimulation effects on <italic>I</italic>
<sub>Ks</sub>, <italic>I</italic>
<sub>CaL</sub> and the kinetics of the latter are shown in Table&#x000a0;<xref rid="tjp12403-tbl-0005" ref-type="table-wrap">5</xref>. DHT application during SNS stimulation affects the kinetics of <italic>I</italic>
<sub>Ca,L</sub>: the activation curve is less steep and is shifted to depolarized potentials compared to baseline (half&#x02010;maximal activation shifted &#x00394;<italic>V</italic>
<sub>1/2</sub>&#x000a0;=&#x000a0;5&#x000a0;mV and slope factor &#x00394;<italic>k</italic>&#x000a0;=&#x000a0;0.4 for DHT 100&#x000a0;nmol&#x000a0;l<sup>&#x02212;1</sup>). The inactivation curve is shifted in the hyperpolarized direction and becomes steeper compared to baseline (half&#x02010;maximal inactivation shifted &#x00394;<italic>V</italic>
<sub>1/2</sub>&#x000a0;=&#x000a0;&#x02212;2.1&#x000a0;mV and slope factor &#x00394;<italic>k</italic>&#x000a0;=&#x000a0;&#x02212;0.3).</p><table-wrap id="tjp12403-tbl-0005" xml:lang="en" orientation="portrait" position="float"><label>Table 5</label><caption><p>Simulated effects of testosterone (DHT) on <italic>I</italic>
<sub>Ks</sub> and <italic>I</italic>
<sub>Ca,L</sub>
</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Channel</th><th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">DHT</th><th align="center" rowspan="1" colspan="1">DHT (SNS stimulation)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10&#x000a0;n<sc>m</sc>
</td><td align="center" rowspan="1" colspan="1">35&#x000a0;n<sc>m</sc>
</td><td align="center" rowspan="1" colspan="1">35&#x000a0;n<sc>m</sc>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>Ks</sub>
</td><td align="center" rowspan="1" colspan="1">1.38</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">3.52</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>CaL</sub>
</td><td align="center" rowspan="1" colspan="1">0.94</td><td align="center" rowspan="1" colspan="1">0.82</td><td align="center" rowspan="1" colspan="1">2.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Kinetics of <italic>I</italic>
<sub>CaL</sub>
</td><td colspan="2" align="center" rowspan="1">No effects</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple" id="tjp12403-list-0003"><list-item><p>
<italic>d</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(&#x02212;(<italic>v</italic>&#x000a0;+&#x000a0;3.94&#x000a0;+&#x000a0;16 &#x02212; 5.0))/4.63]}</p></list-item><list-item><p>
<italic>f</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(<italic>v</italic>&#x000a0;+&#x000a0;19.58&#x000a0;+&#x000a0;8.0&#x000a0;+&#x000a0;2.1)/3.396]}</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Reference</td><td colspan="2" align="center" rowspan="1">Bai <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0003" ref-type="ref">2005</xref>)</td><td align="center" rowspan="1" colspan="1">Table&#x000a0;<xref rid="tjp12403-tbl-0001" ref-type="table-wrap">1</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="tjp12403-tbl5-note-0001"><p>
<italic>v</italic> is membrane potential (mV).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In the simulations, we shifted the <italic>I</italic>
<sub>Ca,L</sub> activation and inactivation curves by the same amount as above experimental data suggested to account for the different dosages of progesterone (see Table&#x000a0;A<xref rid="tjp12403-tbl-0002" ref-type="table-wrap">2</xref>). Also the experimentally observed <italic>I</italic>
<sub>Ca,L</sub> current reduction factor is 0.82 for [DHT]&#x000a0;=&#x000a0;35&#x000a0;n<sc>m</sc> (Table&#x000a0;<xref rid="tjp12403-tbl-0005" ref-type="table-wrap">5</xref>). We used experimental data from 100&#x000a0;n<sc>m</sc> of DHT because 35&#x000a0;n<sc>m</sc> is a maximally stimulating dose of DHT on <italic>I</italic>
<sub>Ca,L</sub> (Table&#x000a0;<xref rid="tjp12403-tbl-0005" ref-type="table-wrap">5</xref>). We then multiplied the scaling factors for <italic>I</italic>
<sub>Ks</sub> and <italic>I</italic>
<sub>Ca,L</sub> when DHT is applied (see Table&#x000a0;<xref rid="tjp12403-tbl-0005" ref-type="table-wrap">5</xref>). Simulated results are in good agreement with experimental data shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0001" ref-type="fig">1</xref>. The effects of progesterone on <italic>I</italic>
<sub>Ca,L</sub> and <italic>I</italic>
<sub>Ks</sub> are shown in Appendix Table <xref rid="tjp12403-tbl-0007" ref-type="table-wrap">A2</xref>. Note that the ISO dose (0.1&#x000a0;&#x003bc;<sc>m</sc>) used in the experiments is a maximally stimulating dose.</p></sec><sec id="tjp12403-sec-0130"><title>Pacing protocol for arousal arrhythmia conditions</title><p>Cells were paced for 400&#x000a0;beats at basic cycle length (BCL) 1200&#x000a0;ms with no protein kinase A (PKA) effects, and followed by 10&#x000a0;beats (BCL&#x000a0;=&#x000a0;800&#x000a0;ms) with PKA application.</p></sec><sec id="tjp12403-sec-0140"><title>Transmural tissue simulations</title><p>We simulated a transmural fibre composed of 360 ventricular cells (&#x00394;<italic>x</italic>&#x000a0;=&#x000a0;&#x00394;<italic>y</italic>&#x000a0;=&#x000a0;100&#x000a0;&#x003bc;m) connected by resistances to simulate gap junctions (Faber &#x00026; Rudy, <xref rid="tjp12403-bib-0024" ref-type="ref">2000</xref>). The fibre contains an endocardial region (cells 1&#x02013;160) and epicardial region (cells 161&#x02013;360), with a linear decrease in APD as indicated by experimental data (Glukhov <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>; Lou <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0059" ref-type="ref">2011</xref>). <italic>G</italic>
<sub>Kr</sub> was used as the index value of endocardium in cell no. 1, and the index value of epicardium in cell no. 360. In the female model, <italic>G</italic>
<sub>Kr</sub> was monotonically increased from 0.036 to 0.042. In the male model, <italic>G</italic>
<sub>Kr</sub> was linearly increased from 0.046 to 0.05. AP simulations were carried out in epi&#x02010;/endocardial cells by changing various ion channel conductances and gap&#x02010;junctions (Yang &#x00026; Clancy, <xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>). The fibre was paced at BCL&#x000a0;=&#x000a0;1200&#x000a0;ms for 500&#x000a0;beats and simulated arousal arrhythmia conditions (see above).</p><p>We simulated a heterogeneous 2D cardiac tissue composed of 360 by 440 cells with &#x00394;<italic>x</italic>&#x000a0;=&#x000a0;&#x00394;<italic>y</italic>&#x000a0;=&#x000a0;150&#x000a0;&#x003bc;m. The tissue contains an endocardial region (fibres 1&#x02013;160) and epicardial region (fibres 161&#x02013;360). Channel conductance and gap&#x02010;junction parameters are the same as in the one&#x02010;dimensional simulations. Current flow is described by the following equation:
<disp-formula id="tjp12403-disp-0001"><mml:math id="nlm-math-1"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:mi>V</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msup><mml:mi>&#x02202;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msup><mml:mi>&#x02202;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:msup><mml:mi>y</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi> ion </mml:mi></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi> stim </mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>V</italic> is the membrane potential, <italic>x</italic> and <italic>y</italic> are distances in the longitudinal and transverse directions, respectively, <italic>D<sub>x</sub></italic> and <italic>D<sub>y</sub></italic> are diffusion coefficients in the <italic>x</italic> and <italic>y</italic> directions, <italic>C</italic>
<sub>m</sub> is membrane capacitance (<italic>C</italic>
<sub>m</sub>&#x000a0;=&#x000a0;1), and <italic>I</italic>
<sub>stim</sub> is 180&#x000a0;mA&#x000a0;cm<sup>&#x02212;2</sup> for the first 0.5&#x000a0;ms. We also incorporated anisotropic effects by setting <italic>D<sub>x</sub></italic> and <italic>D<sub>y</sub></italic> such that the ratio of conduction velocities is 1:2 (Young &#x00026; Panfilov, <xref rid="tjp12403-bib-0106" ref-type="ref">2010</xref>).</p><p>The tissue was first paced for 500&#x000a0;beats at BCL&#x000a0;=&#x000a0;1000&#x000a0;ms on the entire length of one side of tissue prior to application of SNS, and then the 501th beat was paced on the top left corner in an endocardial region with no PKA effects at BCL&#x000a0;=&#x000a0;1000&#x000a0;ms followed by PKA additions in the next beat paced in the same region.</p><sec id="tjp12403-sec-0150"><title>Pseudo&#x02010;ECG computation</title><p>Extracellular unipolar potentials (&#x003a6;<sub>e</sub>) generated by the fibre in an extensive medium of conductivity &#x003c3;<sub>e</sub>, were computed from the transmembrane potential <italic>V</italic>
<sub>m</sub> using the integral expression as in Gima &#x00026; Rudy (<xref rid="tjp12403-bib-0032" ref-type="ref">2002</xref>).</p><p>In one dimension:
<disp-formula id="tjp12403-disp-0002"><mml:math id="nlm-math-2"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x003a6;</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x0222b;</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>&#x02207;</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#x02022;</mml:mo><mml:mfenced separators="" open="[" close="]"><mml:mrow><mml:mi>&#x02207;</mml:mi><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac></mml:mrow></mml:mfenced><mml:mi mathvariant="normal">d</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mi>r</mml:mi></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:msup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p><p>In two dimensions:
<disp-formula id="tjp12403-disp-0004"><mml:math id="nlm-math-3"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x003a6;</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>y</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x0222b;</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>&#x02207;</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#x02022;</mml:mo><mml:mfenced separators="" open="[" close="]"><mml:mrow><mml:mi>&#x02207;</mml:mi><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac></mml:mrow></mml:mfenced><mml:mi mathvariant="normal">d</mml:mi><mml:mi>x</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mi>r</mml:mi></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:msup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>y</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mi>y</mml:mi><mml:mo>&#x02032;</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where &#x02207;<italic>V</italic> is the spatial gradient of <italic>V</italic>
<sub>m</sub>, <italic>a</italic> is the radius of the fibre, &#x003c3;<sub>i</sub> is the intracellular conductivity, &#x003c3;<sub>e</sub> is the extracellular conductivity, and <italic>r</italic> is the distance from a source point (<italic>x</italic>, <italic>y</italic>) to a field point (<italic>x</italic>&#x02032;, <italic>y</italic>&#x02032;). &#x003a6;<sub>e</sub> was computed at an &#x02018;electrode&#x02019; site 2.0&#x000a0;cm away from the distal end along the fibre axis.</p></sec><sec id="tjp12403-sec-0160"><title>Action potential duration mapping</title><p>We reconstructed &#x02018;human transmural myocardial&#x02019; based on data describing transmural action potential heterogeneity mapped from normal human left ventricle (Glukhov <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>) (Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>
<italic>A</italic>). First, the O'Hara&#x02013;Rudy human model was used to generate a <italic>G</italic>
<sub>Kr</sub> lookup table corresponding to APD<sub>80</sub>. Next, an experimental 2D APD<sub>80</sub> map (100&#x000a0;&#x000d7;&#x000a0;100&#x02013;Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>
<italic>A</italic>) was used to create a 2D <italic>G</italic>
<sub>Kr</sub> map using the <italic>G</italic>
<sub>Kr</sub> lookup table. Then the two&#x02010;dimensional <italic>G</italic>
<sub>Kr</sub> values (100&#x000a0;&#x000d7;&#x000a0;100) were used to simulate APD<sub>80</sub>. We paced the female heart at 1&#x000a0;Hz and modified the length of APD<sub>80</sub> to match the clinically observed QT intervals &#x0223c;400&#x000a0;ms (Stramba&#x02010;Badiale <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0092" ref-type="ref">1997</xref>; Ebert <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0022" ref-type="ref">1998</xref>; Nakagawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0066" ref-type="ref">2005</xref>). We then constructed a 3D wedge of 100 by 100 by 1 with &#x00394;<italic>x</italic>&#x000a0;=&#x000a0;&#x00394;<italic>y</italic>&#x000a0;=&#x000a0;200&#x000a0;&#x003bc;m and &#x00394;<italic>z</italic>&#x000a0;=&#x000a0;500&#x000a0;&#x003bc;m using this APD mapping data. Current flow is described by the following equation:
<disp-formula id="tjp12403-disp-0006"><mml:math id="nlm-math-4"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:mi>V</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msup><mml:mi>&#x02202;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msup><mml:mi>&#x02202;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:msup><mml:mi>y</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mspace width="0.16em"/><mml:msub><mml:mi>D</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msup><mml:mi>&#x02202;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>&#x02202;</mml:mi><mml:msup><mml:mi>z</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi> ion </mml:mi></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi> stim </mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>V</italic> is the membrane potential, <italic>D<sub>x</sub></italic>, <italic>D<sub>y</sub></italic> and <italic>D<sub>z</sub></italic> are diffusion coefficients in the <italic>x</italic>, <italic>y</italic> and <italic>z</italic> directions, and <italic>I</italic>
<sub>stim</sub> is 150&#x000a0;mA&#x000a0;cm<sup>&#x02212;2</sup> for 0.5&#x000a0;ms. We also incorporated anisotropic effects by setting <italic>D<sub>x</sub></italic>, <italic>D<sub>y</sub></italic> and <italic>D<sub>z</sub></italic> such that the ratio of conduction velocities is 2:4:1 (Young &#x00026; Panfilov, <xref rid="tjp12403-bib-0106" ref-type="ref">2010</xref>).</p></sec></sec><sec id="tjp12403-sec-0170"><title>Structural model development</title><p>The SWISS&#x02010;MODEL homology modelling program (Kopp &#x00026; Schwede, <xref rid="tjp12403-bib-0048" ref-type="ref">2004</xref>) was used for the development of the hERG model from the available Eag1 channel cryo&#x02010;EM structure (PDB ID 5K7L), determined at 3.78&#x000a0;&#x000c5; resolution (Model 1). A multiple sequence alignment was performed using the CLUSTALW algorithm (Thompson <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0094" ref-type="ref">1994</xref>). Protein models were generated from the alignment in a stepwise manner. The conserved backbone coordinates of the template were preserved in the final model (Wang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0098" ref-type="ref">2016</xref>). The gap regions in the sequence alignment were modelled either from a loop library or through a conformational space search using constrained element methods. The scoring function used for determining side chain conformations was derived from a backbone&#x02010;dependent rotamer library (Benkert <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0006" ref-type="ref">2011</xref>) that accounts for favourable interactions, such as hydrogen bonds and disulfide bridges, as well as unfavourable close contacts. A more detailed description of protocols and sequence alignments used for hERG model generation were provided previously (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>; Anwar&#x02010;Mohamed <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0002" ref-type="ref">2014</xref>; Wang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0098" ref-type="ref">2016</xref>).</p><p>Model 1 was used to study all interactions between E2 and extracellular pore loop residues in both WT and G604S mutant. While this model provides a new template for understanding the effects of mutations in this region, it contains a pore domain in the closed state, and the molecular volume available for binding inside the pore is far too small to accommodate any of the common blockers. Therefore, to study the potential interactions between the channel and hERG blockers, we used a previously developed and experimentally validated model of the hERG pore in the open state (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>; Anwar&#x02010;Mohamed <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0002" ref-type="ref">2014</xref>) based on the Kv1.2 X&#x02010;ray crystal structure (PDB ID 2A79), determined at&#x000a0;2.9&#x000a0;&#x000c5; resolution (Model 2). It is important to stress that this previously published model of the hERG pore displays remarkable structural conservation with the published Eag1 structure for residues critical for drug binding (T623, S624, Y652 and F656), with major differences in the pore loop region far away from the common intra&#x02010;cavity binding site (Wang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0098" ref-type="ref">2016</xref>). To further refine both Model 1 and Model 2 of the hERG channel, we performed molecular dynamics (MD) simulations with a protocol described below.</p></sec><sec id="tjp12403-sec-0180"><title>Molecular docking and MD simulations</title><p>First, the molecular structure of oestradiol (E2) was downloaded from the ZINC database (Irwin <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0040" ref-type="ref">2012</xref>) and the partial charges were recalculated using the GAAMP protocol (Huang &#x00026; Roux, <xref rid="tjp12403-bib-0037" ref-type="ref">2013</xref>). Next, molecular docking was performed using the Glide&#x02010;XP (extra precision) and Induced Fit Docking (IFD) modules of the Maestro suite from Schr&#x000f6;dinger (Gabrielsen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0031" ref-type="ref">2012</xref>) for dofetilide and E2 binding to Model 1 and Model 2. A molecular grid of 36&#x000a0;&#x000c5;&#x000a0;&#x000d7;&#x000a0;36&#x000a0;&#x000c5;&#x000a0;&#x000d7;&#x000a0;36&#x000a0;&#x000c5; was used to map binding pockets on the hERG surface. We followed the recommended protocol for docking of dofetilide and oestradiol including the following steps: (1) constrained minimization of the receptor with a root mean square deviation cutoff of 0.18&#x000a0;&#x000c5;; (2) initial Glide docking of each ligand using soft potentials; (3) refinement of the derived docking poses (i.e. minimization of the protein receptor site within 20&#x000a0;&#x000c5; of the ligand&#x02010;bound area) with Schrodinger's Prime module; and (4) Glide re&#x02010;docking of the protein&#x02013;ligand complexes. Clustering analysis was used to evaluate the docking poses in both the poor loop (using Model 1), and intracellular cavity site (using Model 2). The top&#x02010;scoring pose from each docking simulation was used for MD simulations. We considered five hERG&#x02013;substrate complexes in total, including hERG&#x02013;E2 (pore loop WT), hERG&#x02013;E2 (pore loop G604S), hERG&#x02013;E2 (cavity), hERG&#x02013;dofetilide (cavity), and hERG&#x02013;E2&#x02013;dofetilide (cavity). CHARMM&#x02010;GUI (Jo <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0043" ref-type="ref">2008</xref>) was used to prepare protein&#x02013;dipalmitoylphosphatidylcholine lipid bilayer complexes solvated in 150&#x000a0;m<sc>m</sc> KCl aqueous solution using CHARMM&#x02010;36 force field and TIP3P water model (Jorgensen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0044" ref-type="ref">1983</xref>; MacKerell <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0060" ref-type="ref">1998</xref>; Noskov <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0070" ref-type="ref">2004</xref>; Noskov &#x00026; Roux, <xref rid="tjp12403-bib-0071" ref-type="ref">2008</xref>; Klauda <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0047" ref-type="ref">2010</xref>; Best <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0007" ref-type="ref">2012</xref>). The remaining parameters for oestradiol were generated with MATCH (Yesselman <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0105" ref-type="ref">2012</xref>). The molecular parameters for a neutral form of dofetilide were reported previously (Wang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0098" ref-type="ref">2016</xref>). The fully assembled systems were equilibrated for 10&#x000a0;ns using NAMD2.10 (Phillips <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0080" ref-type="ref">2005</xref>), and production runs were then performed for 50&#x000a0;ns for E2 binding to the WT and G604S mutant pore loop site (Model 1). Both dofetilide and E2 binding to the intracellular cavity (Model 2) were studied with 100&#x000a0;ns MD simulations. All production runs were performed under a constant temperature and pressure (<italic>NPT</italic>) ensemble, with a pressure of 1&#x000a0;atm and temperature of 315.15 K. Long&#x02010;range electrostatic interactions were treated by the particle mesh Ewald (PME) algorithm (Essmann <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0023" ref-type="ref">1995</xref>). Non&#x02010;bonded interactions were switched off at 10&#x02013;12&#x000a0;&#x000c5;. The systems were simulated with a time step of 2 fs under periodic orthorhombic boundary conditions. The ensembles of frames obtained from various MD simulations were used for the calculation of binding enthalpies using a previously developed protocol based on continuum solvent model enthalpies (Robertson <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0081" ref-type="ref">2008</xref>).</p></sec></sec><sec id="tjp12403-sec-0190"><title>Results</title><sec id="tjp12403-sec-0200"><title>Combined effects of sex, SNS and <italic>I</italic>
<sub>Kr</sub> channel blocking drugs</title><p>Clinical and experimental studies have shown that females are especially susceptible to QT&#x02010;interval prolongation by <italic>I</italic>
<sub>Kr</sub> blocking drugs (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>). This finding may partially explain why females are more prone to drug&#x02010;induced arrhythmias (Makkar <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0062" ref-type="ref">1993</xref>; Lehmann <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0055" ref-type="ref">1996</xref>). Hence, we tested the combined effects of hormones and the <italic>I</italic>
<sub>Kr</sub> channel blocker dofetilide on SNS&#x02010;induced arrhythmia triggers.</p><p>Dofetilide is a prototype of the pro&#x02010;arrhythmic class&#x000a0;&#x02013; associated with hERG block, QT prolongation and TdP (Van Opstal <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0096" ref-type="ref">2001</xref>). We recently developed a detailed kinetically based model of the hERG blocker dofetilde by extending the consensus five&#x02010;state Markov chain model that includes three closed states (C<sub>3</sub>, C<sub>2</sub> and C<sub>1</sub>), a conducting open state (O) and an inactivation state (I) (Romero <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0084" ref-type="ref">2014</xref>). The expanded <italic>I</italic>
<sub>Kr</sub> model that includes dofetilide interactions was incorporated into the O'Hara&#x02013;Rudy model of the human ventricular action potential (AP) (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>).</p><p>The dofetilide model, described and validated in detail previously (Romero <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0084" ref-type="ref">2014</xref>), includes the experimentally observed 70&#x02010;fold preferential binding to the inactivated state relative to the open state (Perrin <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0075" ref-type="ref">2008</xref>) and mimics the clinically observed 16% prolongation of the QT interval produced by the therapeutic dose 8.22&#x000a0;n<sc>m</sc> (Demolis <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0014" ref-type="ref">1996</xref>). The effects of the female hormones 17&#x003b2;&#x02010;oestradiol (E2) and progesterone (Pg), the male hormone dihydrotestosterone (DHT) and sex&#x02010;specific genomic&#x02010;based differences in expression of key cardiac channels on human action potentials from this study and O'Hara <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>) and Yang &#x00026; Clancy (<xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>) were also incorporated to develop female and male models as described in more details in Methods above.</p><p>We utilized these male and female models and added the combined effects of dofetilide with acute effects of &#x003b2;&#x02010;adrenergic stimulation by isoproterenol to predict the combined effects of (1) genomic&#x02010;based differences in expression of key cardiac channels, (2) human physiological concentrations of sex hormones, (3) an inherited long&#x02010;QT syndrome and (4) sympathetic arousal that includes an increase in pacing rate.</p></sec><sec id="tjp12403-sec-0210"><title>Simulation of cell&#x02010;level effects of sex&#x02010;based arousal arrhythmias</title><p>Figure&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref> (upper panels) shows the predicted effects of dofetilide to generate arrhythmia triggers in single simulated myocytes in the early follicular phase of the menstrual cycle (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>A</italic>), the late follicular phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>B</italic>), the luteal phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>C</italic>) and in the presence of testosterone (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>D</italic>). Shown are the predicted effects of sex differences and SNS in the setting of acquired long&#x02010;QT syndrome, modelled as the application of dofetilide. Action potentials are shown following pacing for 400 paced&#x000a0;beats at a cycle length of 1200&#x000a0;ms in single simulated endocardial cells. The 399th and 400th paced beats are shown, after which SNS was acutely applied and the pacing cycle length increased to 800&#x000a0;ms to mimic SNS effects on heart rate. Upon acute SNS application arrhythmia triggers were observed in single myocytes (upper panels) in both the early follicular phase of the menstrual cycle (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>A</italic>) and in the late follicular phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>B</italic>). The follicular phases of the menstrual cycle when oestradiol is highest were especially vulnerable. Progesterone was apparently protective during the luteal phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>C</italic>) as was the presence of testosterone (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>D</italic>). These simulations predict that the female cardiac myocytes in the presence of a hERG blocker exhibit arrhythmogenic rhythms upon SNS. When no drug or SNS was applied, no arrhythmogenic rhythms were observed (Appendix Fig. <xref rid="tjp12403-fig-0011" ref-type="fig">A1</xref>).</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Sex&#x02010;based differences in human cardiac electrophysiology predicted in the setting of acquired long&#x02010;QT syndrome induced by dofetilide</title><p>Single cell action potentials were simulated before and during simulated arousal via sympathetic stimulation following pretreatment with dofetilide (top panel <italic>A</italic>&#x02013;<italic>D</italic>). Transmural 1&#x02010;dimensional tissue models and pseudo&#x02010;ECGs were simulated before and during SNS. The pseudo ECG is shown beneath the tissue simulation in each panel. <italic>A</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the early follicular phase of the menstrual cycle. <italic>B</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the late follicular phase of the menstrual cycle. <italic>C</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the luteal phase of the menstrual cycle. <italic>D</italic>, simulated effect of testosterone on male tissue during SNS.</p></caption><graphic id="nlm-graphic-3" xlink:href="TJP-595-4695-g002"/></fig></sec><sec id="tjp12403-sec-0220"><title>Simulation of tissue&#x02010;level effects of sex&#x02010;based arousal arrhythmias</title><p>We also explored the effects of sex&#x02010;based differences in the setting of acquired long&#x02010;QT syndrome type 2 and acute SNS in a one&#x02010;dimensional transmural strand of coupled cells comprising epicardial to endocardial regions (detailed explanation of construction of the tissue is in Methods).</p><p>Figure&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref> (middle and lower panels) illustrates the predicted sex differences in tissue arrhythmia vulnerability during acquired long&#x02010;QT following arousal by SNS. Simulations in one&#x02010;dimensional transmural tissue composed of coupled cells (360&#x000a0;cells) are shown in the presence of 10&#x000a0;n<sc>m</sc> dofetilide during the early follicular phase of the menstrual cycle (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>A</italic>). Time is shown on the <italic>x</italic>&#x02010;axis and voltage on the <italic>z</italic>&#x02010;axis in the middle panels. The corresponding electrograms are shown in each panel below the space&#x02010;time plots. Simulated action potentials (APs) are shown following pacing for 400beats at 1200&#x000a0;ms pacing cycle length. The last 3&#x000a0;beats are shown and then SNS was acutely applied and the cycle length was increased to 800&#x000a0;ms. As shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>B</italic>, the late follicular phases of the menstrual cycle where oestradiol is highest exhibits an arrhythmogenic rhythm triggered by the acute application of SNS. An early afterdepolarization (EAD) initiated in the endocardial region (in the late follicular case shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>B</italic>) generates a sufficient source current to drive full action potential initiation in the downstream excitable (repolarized) epicardial region. The second depolarization during the endocardial EAD results in a self&#x02010;sustaining oscillation derived from a spatially discordant alternans that zig&#x02010;zags back and forth to re&#x02010;excite downstream or upstream cells. The excitatory signal is runaway, as it is a self&#x02010;generating oscillation in the form of a one&#x02010;dimensional reentry. Both an increase in progesterone during the luteal phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>C</italic>) and testosterone in the male tissue (Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>
<italic>D</italic>) were predicted to protect against SNS arrhythmia provocation.</p><p>We next tested the vulnerability to arrhythmia induced by SNS in models of acquired long&#x02010;QT syndrome in simulated human male and female two&#x02010;dimensional tissues as shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref> by simulating a heterogeneous cardiac tissue containing an endocardial region (tissue columns 1 to 160) and an epicardial region (tissue columns 161 to 360) based on recordings from human tissue (Glukhov <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>; Lou <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0059" ref-type="ref">2011</xref>) also incorporating anisotropic effects as described in detail in Methods above. Following pacing for 500&#x000a0;beats (s1) at BCL&#x000a0;=&#x000a0;1000&#x000a0;ms along the entire endocardial length, SNS was then applied with an additional stimulus (s2) after which the simulation ran for 3000&#x000a0;ms without any additional stimulation.</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Female sex is predicted to increase susceptibility to reentrant arrhythmia following acute SNS stimulation in the setting of acquired long&#x02010;QT syndrome induced by dofetilide application</title><p>
<italic>A</italic>&#x02013;<italic>B</italic>, predicted reentrant wave following SNS on female heterogeneous tissue (5.4&#x000a0;cm&#x000a0;&#x000d7;&#x000a0;6.6&#x000a0;cm) containing an endocardial region (tissue columns 1&#x02013;160) and an epicardial region (tissue columns 161&#x02013;360) based on recordings from human tissue, and anisotropic conduction in the presence of female hormones during the early follicular (<italic>A</italic>), late follicular (<italic>B</italic>) and luteal phases (<italic>C</italic>) of the menstrual cycle. <italic>D</italic>, no arrhythmia was predicted in male tissue with 35&#x000a0;n<sc>m</sc> testosterone. Single APs from site &#x02018;a&#x02019; and site &#x02018;b&#x02019; in the simulated tissues are shown in the middle panels for each case. Computed electrograms from simulated tissues are shown in the right panels.</p></caption><graphic id="nlm-graphic-5" xlink:href="TJP-595-4695-g003"/></fig><p>Figure&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref> shows voltage snapshots in time as indicated prior to and following the application of SNS in two&#x02010;dimensional tissue models. The simulated male tissue with testosterone is shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>D</italic>. The 500th paced beat is shown prior to application of SNS. The presence of dofetilide resulted in SNS&#x02010;induced self generated arrhythmias in the female simulated tissues during the early follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>A</italic>) and late follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>B</italic>) phases of the menstrual cycle. The time course of single cell action potentials from two points in space (labelled as &#x02018;a&#x02019; and &#x02018;b&#x02019;) in the simulated 2D tissue and the computed electrograms are shown in the right columns. Site &#x02018;a&#x02019; undergoes two consecutive stimuli (indicated as &#x02018;1st and &#x02018;2nd&#x02019;) at 10&#x000a0;ms and 1010&#x000a0;ms. Sympathetic activation occurs concurrently with the second stimulus. However, the site of activation (near &#x02018;a&#x02019;) becomes a site of reactivation via back&#x02010;propagating action potential conducted from downstream tissue (near &#x02018;b&#x02019;). The tissue near site &#x02018;a&#x02019; then re&#x02010;excites site &#x02018;b&#x02019;, which continues in a feedback loop (observed as an oscillation on the computed electrogram), during which site &#x02018;a&#x02019; maintains depolarization and serves as a persistent current source.</p><p>When progesterone was high during the luteal phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>C</italic>), no arrhythmias were predicted. We also did not observe any arrhythmias in the male model when testosterone was present (Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>D</italic>). Application of dofetilide led to development of spontaneous oscillations in the female only &#x02013; suggesting vulnerability to arrhythmia in the follicular phases of the menstrual cycle. The computed electrograms from the tissue in Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>
<italic>A</italic> and <italic>B</italic> exhibit both periodicity and sinusoidal amplitude, consistent with torsade de pointes type arrhythmias.</p></sec><sec id="tjp12403-sec-0230"><title>Simulation of structural molecular&#x02010;level effects of sex&#x02010;based arousal arrhythmias</title><p>The cellular&#x02010; and tissue&#x02010;level simulations discussed above suggest that cardiac ion channel hormone interactions may constitute an important component of sex&#x02010;based arousal arrhythmias with <italic>I</italic>
<sub>Kr</sub> current modulation playing a central role. Experimentally the reduction of <italic>I</italic>
<sub>Kr</sub> resulting from the action of oestradiol on the hERG channel has been demonstrated previously (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>); however, the molecular&#x02010;level interactions that underlie this effect remain uncharacterized. As a first step to identify potential binding sites as well as key stabilizing interactions between ligand and receptor, we carried out molecular docking of dofetilide (Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>A</italic>) and E2 (Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>B</italic>) to the intra&#x02010;cellular cavity (IC) of the WT open&#x02010;state hERG atomistic model (Model 2) developed previously (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0020" ref-type="ref">2011</xref>, <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>).</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Top scoring docking poses for dofetilide (<italic>A</italic> and <italic>C</italic>) and oestradiol (<italic>B</italic> and <italic>C</italic>) in the intracellular cavity (IC) site of hERG</title><p>Left panels: pore domain of the hERG open state model and selected frames showing dofetilide (pink) (<italic>A</italic>), and E2 (green) (<italic>B</italic>), binding to the IC. Right panels: average position of dofetilide (<italic>A</italic>), and E2 (<italic>B</italic>) shown together with coordinating residues within 3.5 &#x000c5; for two mapped binding sites. Two&#x000a0;dominant binding orientations are shown in magenta and pink for dofetilide (<italic>A</italic>), and in green and&#x000a0;light&#x02010;blue for E2 (<italic>B</italic>). The relative orientation of dofetilide (pink) and E2 (light&#x02010;blue), as well as the dominant interacting residues in the hERG IC site, are shown in <italic>C</italic>.</p></caption><graphic id="nlm-graphic-7" xlink:href="TJP-595-4695-g004"/></fig><p>The simulations showed that a clustering of dofetilide poses that provides additional confirmation that dofetilide interacts with binding pocket for common hERG blockers (Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>A</italic>; Vandenberg <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0095" ref-type="ref">2001</xref>; Ficker <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0026" ref-type="ref">2001</xref>; Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>). E2 poses and follow&#x02010;up MD simulations led to identification of two tentative binding pockets with favourable binding docking scores for the oestradiol molecule. The high&#x02010;affinity site, shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>B</italic>, is located in the intracellular cavity of hERG and overlaps with a binding pocket for common hERG blockers including dofetilide (as shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>A</italic>) (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>). To provide in&#x02010;depth analysis of E2 dynamics in this IC site, we performed 100&#x000a0;ns MD simulations of the hERG&#x02013;E2 complex in explicit lipid bilayers. The oestradiol molecule exhibits substantial flexibility in the IC of hERG, resulting in a broad distribution of binding enthalpies. However, most of them are in the &#x02212;10 to &#x02212;15&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup> range with a mean value around &#x02212;12&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup>, which (without taking into account entropic contribution) corresponds to low micromolar/potent blocking affinity (Zachariae <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0107" ref-type="ref">2009</xref>; Anwar&#x02010;Mohamed <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0002" ref-type="ref">2014</xref>). Similar to many other blockers, oestradiol explores both low&#x02010; and high&#x02010;affinity sites in the IC of hERG channel (Duff <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0018" ref-type="ref">1995</xref>; Lees&#x02010;Miller <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0053" ref-type="ref">2000</xref>). Analysis of MD simulations shows that the most dominant binding pocket for E2 relies on a combination of &#x003c0;&#x02010;stacking interactions of Y652 and F656 rings with an aromatic centroid of E2, supplemented by hydrogen bonding with the constellation of T623/S624 in the pore helix region and S645 in the S6 helix.</p><p>The second binding site is defined by the aromatic F656 side&#x02010;chain, supplemented by a number of hydrophobic residues including L650 and A653. Y652 is also transiently involved into coordination of bound oestradiol at this site. It is apparent that the main determinant of binding is whether the F656&#x02013;E2 interaction can be stabilized by the additional hydrophobic interactions. Kurokawa <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>) have shown that E2 does not inhibit both F656T and F656M mutant hERG currents, which is in agreement with the theoretical results presented here. It is notable that the relatively small size of oestradiol allows for another orientation in the binding pocket, where the bound hormone is oriented along the two distal S6 helices from adjacent subunits.</p><p>The E2 IC binding site is adjacent to that of dofetilide (see Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref>
<italic>C</italic>), suggesting a likely interaction. In fact, our binding enthalpy calculations from MD simulations demonstrated that the presence of intracellular cavity bound E2 leads to a modestly more favourable binding of dofetilide (by around 1.2&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup>). Also, the width of the distribution for dofetilide binding energies is much narrower with E2 bound to IC of hERG channel. All this suggests that a presence of E2 can potentially enhance hERG block by dofetilide, and thus enhance its proclivity to promote arrhythmia. The combination of molecular docking, MD simulations and binding enthalpy computations in conjunction with electrophysiology data provides consistent evidence for IC blocker action of E2.</p></sec><sec id="tjp12403-sec-0240"><title>Simulation of cellular&#x02010;level effects of inherited sex&#x02010;based arousal arrhythmias</title><p>We next extended the O'Hara&#x02013;Rudy computational model (O'Hara <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0073" ref-type="ref">2011</xref>) of <italic>I</italic>
<sub>Kr</sub> to include the functional effects of the cardiac pore loop mutation G604S. As shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0005" ref-type="fig">5</xref>
<italic>A</italic> and <italic>B</italic>, the mutant G604S <italic>I</italic>
<sub>Kr</sub> model was developed by optimizing parameters to experimental data for current&#x02013;voltage relationships of peak and tail currents of G604S <italic>I</italic>
<sub>Kr</sub> recorded from HEK cells. In Fig.&#x000a0;<xref rid="tjp12403-fig-0005" ref-type="fig">5</xref>
<italic>A</italic> and <italic>B</italic>, the adjusted, model&#x02010;generated <italic>I</italic>
<sub>Kr</sub> (lines) is shown superimposed on experimental <italic>I</italic>
<sub>Kr</sub> records (symbols). The normalized <italic>I</italic>
<sub>Kr</sub> current&#x02013;voltage relationship for peak current for WT (black) and the hERG&#x02010;G604S mutation (red) are shown in panel (A). In panel (B) there are current&#x02013;voltage relationships from normalized tail currents for WT (blue) and hERG&#x02010;G604S mutant channels (red).</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Simulated and experimentally recorded <italic>I</italic>
<sub>Kr</sub> data</title><p>Model&#x02010;generated <italic>I</italic>
<sub>Kr</sub> (lines) is shown superimposed on experimental <italic>I</italic>
<sub>Kr</sub> records (symbols with error bars, <italic>n</italic>&#x000a0;=&#x000a0;9) from HEK cells (Huo <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0039" ref-type="ref">2008</xref>). <italic>A</italic>, normalized <italic>I</italic>
<sub>Kr</sub> current&#x02013;voltage relationship for peak current for WT (blue) and the hERG&#x02010;G604S mutation (red). <italic>B</italic>, current&#x02013;voltage relationships from normalized tail currents for WT (blue) and hERG&#x02010;G604S mutant channels (red).</p></caption><graphic id="nlm-graphic-9" xlink:href="TJP-595-4695-g005"/></fig><p>To determine the sex&#x02010;based propensity for arousal&#x02010;induced arrhythmias, we added the combined effects of the long&#x02010;QT syndrome type 2 pore mutation G604S with acute effects of &#x003b2;&#x02010;adrenergic stimulation by isoproterenol. Figure&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref> shows the predicted effects on arrhythmia triggers in single simulated myocytes (upper rows) in female and male models. These results indicate that the female cells in the presence of the G604S pore mutation, particularly in the follicular phases of the menstrual cycle when oestradiol is highest, are considerably more vulnerable to the emergence of arrhythmogenic rhythms upon SNS.</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><title>Simulated arousal via sympathetic stimulation in the setting of the G604S mutation causing inherited long&#x02010;QT syndrome type 2</title><p>Single cell action potentials are shown at the top of each panel. Transmural 1&#x02010;dimensional tissue models are shown in the middle. Time is shown on the <italic>x</italic>&#x02010;axis and voltage on the <italic>z</italic>&#x02010;axis. The pseudo ECG is shown beneath the tissue simulation in each panel. <italic>A</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the early follicular phase of the menstrual cycle. <italic>B</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the late follicular phase of the menstrual cycle. <italic>C</italic>, simulated combined effects of oestradiol and progesterone on female tissues during the luteal phase. <italic>D</italic>, simulated effect of testosterone on male tissue during SNS.</p></caption><graphic id="nlm-graphic-11" xlink:href="TJP-595-4695-g006"/></fig></sec><sec id="tjp12403-sec-0250"><title>Simulation of tissue&#x02010;level effects of inherited sex&#x02010;based arousal arrhythmias</title><p>We next explored the effects of sex&#x02010;based differences in the setting of inherited long&#x02010;QT syndrome type 2 pore mutation G604S and acute SNS in a one&#x02010;dimensional transmural strand of coupled cells comprising epicardial to endocardial regions. The middle panels in Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>A</italic>&#x02013;<italic>C</italic> (middle rows) show the sex&#x02010;based effects in an electrically coupled female tissue during the early follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>A</italic>), late follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>B</italic>) and luteal (Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>C</italic>) phases of the menstrual cycle. The male tissue with testosterone present is shown in the middle of Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>D</italic>. We also computed electrograms (lower panels) in female and male virtual tissues (Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>).</p><p>Importantly, the simulation shows longer repolarization in the female compared to male tissues following SNS, consistent with the longstanding observations that females have longer corrected QT intervals than males (Jose &#x00026; Collison, <xref rid="tjp12403-bib-0045" ref-type="ref">1970</xref>; Huikuri <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0038" ref-type="ref">1996</xref>; Burke <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0010" ref-type="ref">1997</xref>; Stramba&#x02010;Badiale <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0092" ref-type="ref">1997</xref>; Bidoggia <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0008" ref-type="ref">2000</xref>; Smetana <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0088" ref-type="ref">2002</xref>). The prolonged T&#x02010;wave in females corresponds to longer APD (as observed in the space&#x02013;time plot) and is likely to contribute to the arrhythmogenic rhythm that emerges in the late follicular phase (Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>B</italic>). Note that the computed electrogram from the tissue in Fig.&#x000a0;<xref rid="tjp12403-fig-0006" ref-type="fig">6</xref>
<italic>B</italic> exhibits both periodicity and sinusoidal amplitude, consistent with torsade de pointes type arrhythmias.</p><p>We also tested the vulnerability to arrhythmia induced by SNS with the LQT2 G604S hERG pore mutation in simulated human male and female two&#x02010;dimensional tissues using the same protocol as described in Fig.&#x000a0;<xref rid="tjp12403-fig-0003" ref-type="fig">3</xref>. Figure&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref> shows voltage snapshots in time as indicated prior to and following the application of SNS in female tissue in simulated phases corresponding to early follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>A</italic>), late follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>B</italic>) and luteal (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>C</italic>) phases of the menstrual cycle. The simulated male tissue with testosterone is shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>D</italic>. Simulations are shown following pacing from the endocardium for 500&#x000a0;beats at 1000&#x000a0;ms pacing cycle length. The 500th paced beat is shown prior to application of SNS. In the presence of testosterone (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>D</italic>) or high progesterone (luteal phase in Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>C</italic>) application of SNS is not predicted to be arrhythmia provoking.</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0007" orientation="portrait" position="float"><label>Figure 7</label><caption><title>Female sex is predicted to increase susceptibility to reentrant arrhythmia following acute SNS stimulation in the setting of inherited LQT2 syndrome</title><p>
<italic>A&#x02013;C</italic>, predicted reentrant wave following SNS on female heterogeneous tissue (5.4&#x000a0;cm&#x000a0;&#x000d7;&#x000a0;6.6&#x000a0;cm) containing an endocardial region (tissue columns 1&#x02013;160) and an epicardial region (tissue columns 161&#x02013;360) based on recordings from human tissue, and anisotropic conduction in the presence of female hormones during the early follicular (<italic>A</italic>), late follicular (<italic>B</italic>) and luteal (<italic>C</italic>) phases of the menstrual cycle. <italic>D</italic>, no arrhythmia was predicted in male tissue with 35&#x000a0;n<sc>m</sc> testosterone. Computed electrograms from simulated tissues are shown in the right panels.</p></caption><graphic id="nlm-graphic-13" xlink:href="TJP-595-4695-g007"/></fig><p>The outcome was starkly different in the female simulated tissue during the early (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>A</italic>) and late follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>B</italic>) phases, which following SNS application developed spontaneous focal arrhythmia activity &#x02013; in these cases, the oscillations persist for more than 3&#x000a0;s. The development of spontaneous sustained oscillations suggests female vulnerability to arrhythmia is especially noticeable during the follicular phases of the menstrual cycle. The computed electrograms from the simulated tissues are shown in the right panels, clearly illustrating the abrupt degeneration of the electrical rhythm following acute SNS in Fig.&#x000a0;<xref rid="tjp12403-fig-0007" ref-type="fig">7</xref>
<italic>A</italic> and <italic>B</italic>. Notably, in the absence of either the G604S pore mutation or SNS, no arrhythmia was observed at the cell (Appendix Fig.&#x000a0;<xref rid="tjp12403-fig-0011" ref-type="fig">A1</xref>) and tissue levels (Appendix Fig.&#x000a0;<xref rid="tjp12403-fig-0012" ref-type="fig">A2</xref>).</p><p>Finally, because a three&#x02010;dimensional tissue is a larger electrotonic sink, we set out to test if the predictions of female vulnerability to SNS&#x02010;induced arrhythmia in the setting of long&#x02010;QT syndrome type 2 would persist in higher dimensions. We developed an <italic>in silico</italic> left ventricular 3D wedge reconstruction of the human female based on the experimental data from Glukhov <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>) with the pore loop G604S mutation (Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>). Even in the 3D wedge reconstruction, we observed arousal&#x02010;induced spontaneous arrhythmias in the early follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>
<italic>A</italic>) and late follicular (Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>
<italic>B</italic>) phases of menstrual cycle by acute SNS application. Just as in lower dimensions, the luteal phase is not predicted to be sensitive to SNS (Fig.&#x000a0;<xref rid="tjp12403-fig-0008" ref-type="fig">8</xref>
<italic>C</italic>).</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0008" orientation="portrait" position="float"><label>Figure 8</label><caption><title>
<italic>In silico</italic> 3D reconstructed human long&#x02010;QT syndrome type 2 female LV wedge based on Glukhov <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>) paced with SNS applied</title><p>
<italic>A</italic>, reconstruction of a human tissue <italic>in silico</italic> from normal female explanted heart at a pacing rate of 1&#x000a0;Hz. Experimental data from normal human left ventricle (Glukhov <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0033" ref-type="ref">2010</xref>) shown at the top. <italic>B</italic>&#x02013;<italic>C</italic>, simulated tissue and pseudo ECG are shown in the bottom panel. In the early follicular (<italic>B</italic>) and late follicular (<italic>C</italic>) phases of the menstrual cycle, SNS application initiates arrhythmia. <italic>D</italic>, the luteal phase is not predicted to be sensitive to SNS. APD variability is indicated by the colour scale from long APD<sub>80</sub> (red) to short (blue).</p></caption><graphic id="nlm-graphic-15" xlink:href="TJP-595-4695-g008"/></fig></sec><sec id="tjp12403-sec-0260"><title>Ionic mechanisms of arrhythmia vulnerability in females</title><p>We next utilized a component dissection approach to determine the mechanism of self&#x02010;generated arrhythmia triggers in the late follicular phase of the menstrual cycle. Because PKA activity results in increases in two inward currents, <italic>I</italic>
<sub>Na</sub> and <italic>I</italic>
<sub>CaL</sub>, it is difficult to assess which effect is required to promote arrhythmogenic early afterdepolarizations. Thus, we selectively blocked the individual effects of PKA facilitation of <italic>I</italic>
<sub>Na</sub> and <italic>I</italic>
<sub>Ca</sub>, while maintaining all other effects. The 399th&#x02013;400th&#x000a0;beats (red arrows) are shown prior to application of SNS. Upon SNS application, the pacing cycle length was increased to 800&#x000a0;ms for 100&#x000a0;beats. The last 11 of 100&#x000a0;beats (BCL&#x000a0;=&#x000a0;800&#x000a0;ms, under SNS stimulations) are shown in the right panels. As can be seen in Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>A</italic>&#x02013;<italic>C</italic>, the blocking PKA effects on <italic>I</italic>
<sub>CaL</sub> alone was sufficient to prevent arrhythmia triggers, which did not emerge even after 100&#x000a0;beats (right panels). On the other hand, blocking the effects of PKA on <italic>I</italic>
<sub>Na</sub> (Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>D</italic>&#x02013;<italic>F</italic>) did not prevent afterdepolarizations, which persisted after 100 additional beats (right panels). Finally, based on recent data from the Salama group, we examined the effect of increasing <italic>I</italic>
<sub>NCX</sub> (NCX is a sodium&#x02013;calcium exchanger) density by 2&#x02010;fold (Chen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0011" ref-type="ref">2011</xref>) in the epicaridum as shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>G</italic>&#x02013;<italic>I</italic>. The cell (Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>G</italic>, red line) and coupled tissue (Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>H</italic>) exhibited an exacerbation of proarrhythmia when the <italic>I</italic>
<sub>NCX</sub> density was increased compared with no changes in <italic>I</italic>
<sub>NCX</sub> (black line). The effect on the computed electrogram is shown as a tachycardic rhythm in Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>
<italic>I</italic>.</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0009" orientation="portrait" position="float"><label>Figure 9</label><caption><title>Ionic mechanisms of simulated arousal via sympathetic stimulation in the setting of inherited or acquired LQT during late follicular phase</title><p>Since ISO increased <italic>I</italic>
<sub>caL</sub> and <italic>I</italic>
<sub>Na</sub>, here we investigated which current induced EAD. <italic>A</italic>&#x02013;<italic>C</italic> suggested that when we removed PKA effects on <italic>I</italic>
<sub>caL</sub> (<italic>B</italic>), there was no EAD induction. The 399th&#x02013;400th (red arrows) are shown prior to application of SNS. Upon SNS application, the pacing cycle length was increased to 800&#x000a0;ms for 100&#x000a0;beats. The last 11&#x000a0;beats (BCL&#x000a0;=&#x000a0;800&#x000a0;ms, under SNS stimulations) are shown in the right panels. <italic>D</italic>&#x02013;<italic>F</italic> show that eliminating PKA effects on <italic>I</italic>
<sub>Na</sub> (<italic>F</italic>) does not suppress EAD&#x02010;triggered activity. <italic>G</italic>, <italic>I</italic>
<sub>NCX</sub> densities were increased by 2&#x02010;fold (Chen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0011" ref-type="ref">2011</xref>) in epi cell (red line) compared with no changes in <italic>I</italic>
<sub>NCX</sub> (black line). <italic>H</italic>, transmural 1&#x02010;dimensional tissue models with upregulation of NCX in epicardium. <italic>I</italic>, the pseudo ECG is shown beneath the tissue simulation.</p></caption><graphic id="nlm-graphic-17" xlink:href="TJP-595-4695-g009"/></fig><p>The explanation for this mechanism can be traced back in part to the effects of hormones on the <italic>I</italic>
<sub>CaL</sub> window current. Progesterone and testosterone cause a dose&#x02010;dependent reduction in <italic>I</italic>
<sub>CaL</sub> window current (Appendix Fig.&#x000a0;<xref rid="tjp12403-fig-0013" ref-type="fig">A3</xref>). During the follicular phases of the menstrual cycle, low progesterone (2.5&#x000a0;n<sc>m</sc>) does not sufficiently reduce the <italic>I</italic>
<sub>CaL</sub> window current, which when combined with reduced hERG current due to long&#x02010;QT syndrome type 2 mutations or drugs, resulted in increased susceptibility to EADs in female myocytes during the follicular phase. Our simulations suggest that EADs were initiated by a perfect storm of PKA effects, acute hormone effects on <italic>I</italic>
<sub>CaL</sub> and <italic>I</italic>
<sub>Kr</sub> suppression by the long&#x02010;QT syndrome type 2 mutation or dofetilide (Appendix Fig.&#x000a0;<xref rid="tjp12403-fig-0014" ref-type="fig">A4</xref>). At the tissue level, there is an additional effect in the female of reduced gap junction conductance, incorporated in our model based on the observation of reduced Cx43 in female <italic>versus</italic> male hearts (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0030" ref-type="ref">2010</xref>; Yang &#x00026; Clancy, <xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>). Reduced gap junction coupling (Xie <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0101" ref-type="ref">2010</xref>) in the female relative to male (Appendix Table&#x000a0;<xref rid="tjp12403-tbl-0006" ref-type="table-wrap">A1</xref>) is predicted to promote the development of EADs, by creating a source&#x02013;sink mismatch that allows for triggered activity in groups of cells to initiate reentry in tissue.</p></sec><sec id="tjp12403-sec-0270"><title>Structure&#x02010;based mechanisms of arrhythmia vulnerability in females</title><p>Similar to female predominance of arrhythmia in the acquired setting, which suggests interactions between hERG, dofetilide and oestradiol, the female predominance of inherited arrhythmia linked the the G604S mutations, suggests that oestradiol may differentially interact with the mutant hERG channel compared to WT. To probe a possible molecular mechanism, we utilized the molecular docking of oestrogen throughout hERG and identified a second E2 binding site located near the pore loop region discovered in molecular docking studies performed with hERG Model 1 (based on the Eag1 template) described above that involves a number of residues implicated in gating dynamics. In the WT, this site is exposed to the lipid bilayer, allowing for easy access to oestradiol (Fig.&#x000a0;<xref rid="tjp12403-fig-0010" ref-type="fig">10</xref>
<italic>A</italic>, left). The estimated binding affinity of &#x02212;5.4&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup> places E2 in the cohort of weak binders with the estimated pIC<sub>50</sub> (a negative log of 50% inhibition coefficient) &#x0003c;4.5, comparable to carvedilol block of WT hERG (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>; Anwar&#x02010;Mohamed <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0002" ref-type="ref">2014</xref>). The MD simulations of E2 to this binding site show that oestradiol displays a very broad range of docking poses, and can rapidly unbind and diffuse away from this low&#x02010;affinity site to lipid bilayer. Notably, this site hosts the G604S pore loop mutation, implicated in female proclivity to arousal arrhythmia.</p><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0010" orientation="portrait" position="float"><label>Figure 10</label><caption><title>Oestradiol (E2) binding to a pore loop site of hERG from molecular docking (<italic>A</italic>), and molecular dynamics (<italic>B</italic> and <italic>C</italic>) simulations for wild&#x02010;type (WT; left) and G604S mutant hERG channel (right)</title><p>
<italic>A</italic>, top scoring docking poses for dofetilide in the pore loop site shown together with coordinating residues within 3.5&#x000a0;&#x000c5; for mapped binding sites. <italic>B</italic>, E2 positions (shown in green wireframe representation) are mapped from the frames collected in 40&#x000a0;ns MD for WT and G604S in order to illustrate the conformational space explored by the ligand in the two systems. It is apparent that E2 is kinetically stabilized (trapped) in the G604S mutant, while it is unable to bind stably in WT and leaves the binding pocket within 20&#x000a0;ns of MD simulation. <italic>C</italic>, a G604S mutation is predicted to enhance stability of the bound E2 (green wireframe) in the binding pocket by controlling binding site flexibility: the mutation stabilizes the binding site allowing for E2 to remain in the pocket. In contrast, E2 readily leaves binding pocket in the WT hERG protein and diffuses away to the lipid bilayer. Shown are 32 selected frames from the first 15&#x000a0;ns of molecular dynamics simulation for E2/WT and E2/G604S are shown in different colours.</p></caption><graphic id="nlm-graphic-19" xlink:href="TJP-595-4695-g010"/></fig><p>This pore loop region appears to be a unique structural feature of both Eag and Erg channels. MD simulations suggest that E2 dissociates rapidly from this site in WT and hence is unlikely to impair function of WT hERG channel. In order to investigate how this specific mutation G604S affects oestradiol binding at the pore loop receptor site, we mutated our WT hERG model accordingly, and again used molecular docking to identify key binding motifs, shown in the left and right panels of Fig.&#x000a0;<xref rid="tjp12403-fig-0010" ref-type="fig">10</xref>
<italic>A</italic> for WT and G604S, respectively.</p><p>The MD simulations of the G604S&#x02013;E2 complex are in stark contrast with results we obtained for WT channel. Molecular docking alone results in indistinguishable binding enthalpies of E2 between WT and G604S: &#x02212;6.1&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup>
<italic>vs</italic>. &#x02212;5.4&#x000a0;kcal&#x000a0;mol<sup>&#x02212;1</sup>, respectively. However, MD simulations reveal major differences in conformational dynamics of the pore loop region with E2 bound in WT and G604S. The clustering of E2 poses on the hERG extracellular loop in WT and mutant proteins is shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0010" ref-type="fig">10</xref>
<italic>B</italic>. The RMS fluctuations show that the mobility/flexibility is much lower when E2 is bound to the G604S mutant compared to WT (Fig.&#x000a0;<xref rid="tjp12403-fig-0010" ref-type="fig">10</xref>
<italic>C</italic> and Appendix Fig.&#x000a0;<xref rid="tjp12403-fig-0015" ref-type="fig">A5</xref>). When E2 is bound to the G604S mutant, interaction remains stable throughout the 50&#x000a0;ns MD, whereas E2 departs from the WT channel within 20&#x000a0;ns (Fig.&#x000a0;<xref rid="tjp12403-fig-0010" ref-type="fig">10</xref>
<italic>C</italic>).</p><p>These results suggest that the pore loop mutation enhances binding of E2 to the hERG channel. They also suggest that the enhanced affinity is not due to key interactions between the G604 mutated residue and E2, but rather the interplay between conformational and flexibility changes resulting from the mutation. Vandenberg and colleagues (Pages <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0074" ref-type="ref">2009</xref>) suggested that dynamics and flexibility of this region is critical for the stability of the selectivity filter and therefore is expected to play a substantial role in inactivation dynamics.</p></sec></sec><sec id="tjp12403-sec-0280"><title>Discussion</title><p>&#x02018;It has only been possible to collect a few figures for normal women, but so many of these fall outside the range for normal men,&#x02019; wrote Bazett in his 1920 analysis of cardiac electrical activity (Bazett, <xref rid="tjp12403-bib-0004" ref-type="ref">1997</xref>). Nearly a century has passed since the initial recognition of sex&#x02010;based differences in cardiac electrical activity. Yet, even now, there is a little known about the <italic>structural and functional mechanisms</italic> underlying the sex&#x02010;based differences that predispose human women to inherited and acquired long&#x02010;QT syndrome and associated torsade de pointes (TdP) arrhythmias (Makkar <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0062" ref-type="ref">1993</xref>; Locati <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0058" ref-type="ref">1998</xref>; Salama &#x00026; Bett, <xref rid="tjp12403-bib-0085" ref-type="ref">2014</xref>).</p><p>Recent experimental studies in a rabbit model of acquired long&#x02010;QT syndrome show an increased risk for arrhythmia and TdP in adult female hearts that is not observed in pre&#x02010;pubescent female or adult male hearts (Liu <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0057" ref-type="ref">2005</xref>; Sims <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0087" ref-type="ref">2008</xref>). In these studies, oestrogen&#x02010;dependent genomic upregulation of <italic>I</italic>
<sub>Ca,L</sub> and <italic>I</italic>
<sub>NCX</sub> were implicated as possible contributors to TdP in females (Chen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0011" ref-type="ref">2011</xref>; Yang <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0104" ref-type="ref">2012</xref>). However, these studies did not address the impact of the autonomic nervous system that apparently impacts arrhythmia risk in females. Our predictions (Fig.&#x000a0;<xref rid="tjp12403-fig-0009" ref-type="fig">9</xref>) do support the idea that upregulation of NCX may promote arrhythmias in females. A population study by Kim <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0046" ref-type="ref">2010</xref>) showed that 82% of observed arousal&#x02010;induced arrhythmias occurred in females.</p><p>Because sympathetic discharge is a well&#x02010;recognized factor in triggering TdP in long&#x02010;QT syndrome patients, the combined effects of protein kinase A (PKA) phosphorylation and sex hormones on ion channels have recently been studied experimentally (Furukawa &#x00026; Kurokawa, <xref rid="tjp12403-bib-0028" ref-type="ref">2007</xref>; Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>; Vaseghi &#x00026; Shivkumar, <xref rid="tjp12403-bib-0097" ref-type="ref">2008</xref>). Progesterone was shown to prevent PKA&#x02010;mediated increases in depolarizing current through the <italic>I</italic>
<sub>Ca,L</sub>, while enhancing the effect of PKA&#x02010;induced repolarizing <italic>I</italic>
<sub>Ks</sub> (Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>). The net effect of these two changes is to increase repolarizing current and reduce APD. In this study, we also included new data showing the effects of testosterone on the L&#x02010;type Ca<sup>2+</sup> current in the presence of isoproterenol (Fig.&#x000a0;<xref rid="tjp12403-fig-0001" ref-type="fig">1</xref>). Just as has been shown for progesterone in a previous study (Nakamura <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>), testosterone application blunted the isoproterenol&#x02010;induced enhancement of the L&#x02010;type Ca<sup>2+</sup> current. This provides a plausible mechanism for testosterone protection against arousal&#x02010;induced arrhythmias: a reduction in L&#x02010;type Ca<sup>2+</sup> current allows for greater rate&#x02010;dependent shortening of the male action potential and reduces arrhythmia likelihood.</p><p>Women are disproportionately affected by inherited forms of long&#x02010;QT syndrome associated with hERG pore loop mutations as well as by acquired long&#x02010;QT syndrome, which results from unintended off&#x02010;target block of the major cardiac repolarizing current <italic>I</italic>
<sub>Kr</sub>, encoded by the hERG gene and characterized by prolongation of the QT interval. The basis of our study was the hypothesis that oestrogen will acutely increase arrhythmia vulnerability and that progesterone will protect against arrhythmia initiation, especially in the setting of sympathetic stimulation, a major factor in triggering TdP. This hypothesis is based on published data showing that oestrogen interacts directly with the promiscuous hERG channel, reduces repolarizing <italic>I</italic>
<sub>Kr</sub> current and increases the rate of channel deactivation (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>). Kurokawa and co&#x02010;authors proposed that aromatic centroid of E2 may be responsible for increasing the sensitivity of hERG block by E4031 via interaction with the aromatic side chain of Phe&#x02010;656 and aromatic rings of the hERG blocker.</p><p>Kurokawa and co&#x02010;authors have also shown that in the presence of E2, hERG is markedly more sensitive to block by drugs and that the concentration of E2 fluctuates throughout the menstrual cycle, from the peak follicular phase serum E2 level of 1&#x000a0;n<sc>m</sc> to 0.7&#x000a0;n<sc>m</sc> in the luteal phase (Kurokawa <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0051" ref-type="ref">2008</xref>). Since E2 has dramatic effects on sensitivity to hERG block within this range, it stands to reason that susceptibility to drug&#x02010;induced arrhythmia by hERG block may also vary through the menstrual cycle, but the exact mechanism of potential concomitant effects on common blocker action remain unknown. The predictions from molecular modelling studies based on bacterial KcsA and MthK (Perry <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0076" ref-type="ref">2004</xref>; Stansfeld <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0089" ref-type="ref">2007</xref>) channels or the mammalian channel Kv1.2 (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0021" ref-type="ref">2010</xref>; Stary <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0090" ref-type="ref">2010</xref>) concur with the experimental findings that have revealed two key residues responsible for drug stabilization in the hERG1 cavity, e.g. Y652 and F656 (Lees&#x02010;Miller <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0053" ref-type="ref">2000</xref>; Mitcheson <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0063" ref-type="ref">2000</xref>; Ficker <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0026" ref-type="ref">2001</xref>; Vandenberg <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0095" ref-type="ref">2001</xref>; Fernandez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0025" ref-type="ref">2004</xref>; Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>). Model studies reproduced this feature in studies of hERG blockers such as dofetilide, KN&#x02010;93 and other common high&#x02010;affinity blockers (Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0020" ref-type="ref">2011</xref>, <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>).</p><p>Previous studies of high&#x02010; and low&#x02010;affinity blockers such as dofetilide, astemizole and haloperidole suggest that an &#x02018;ideal&#x02019; high&#x02010;affinity blocker should simultaneously interact with F656, Y652 and/or A653 at the inner cavity of hERG, and form hydrogen bonds with T623 and S624 from the pore helix (Mitcheson <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0063" ref-type="ref">2000</xref>; Lees&#x02010;Miller <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0053" ref-type="ref">2000</xref>; Ficker <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0026" ref-type="ref">2001</xref>; Fernandez <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0025" ref-type="ref">2004</xref>; Durdagi <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0020" ref-type="ref">2011</xref>, <xref rid="tjp12403-bib-0019" ref-type="ref">2012</xref>; Vandenberg <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0095" ref-type="ref">2001</xref>). The binding data collected from our MD simulations shown in Fig.&#x000a0;<xref rid="tjp12403-fig-0004" ref-type="fig">4</xref> endorse the presence of these sites accommodating favourable and synergistic binding of both E2 and dofetilide. The distribution of binding energies and binding pockets for E2 and dofetilide suggest a plausible scenario of hormone modification of common blocker action. In the intracellular cavity (IC) of hERG, the presence of E2 only modestly enhances the binding affinity of dofetilide; however, there is less variance in the distribution of binding energies for dofetilide with E2 bound. That is, bound hormone stabilizes the high&#x02010;affinity site for dofetilide and virtually eliminates binding to a low&#x02010;affinity site.</p><p>The hERG channel exhibits a high degree of homology with the Eag1 channel, the structure of which has recently been determined (Whicher &#x00026; MacKinnon, <xref rid="tjp12403-bib-0099" ref-type="ref">2016</xref>). The availability of the Eag1 structure provided us with a new and unique structural template for understanding arrhythmia&#x02010;associated mutations.</p><p>A key feature revealed by the structure is the extended &#x02018;extracellular turret&#x02019;. Indeed, this region is home to the G406S mutation studied here, and we found that it appears to provide a pocket for oestrogen binding that is stabilized by the mutation. The new structural data allowed the revelation of interactions between physiologically important and tightly controlled lipophilic substances such as E2 and functionally important lipid&#x02010;facing regions of the hERG channel. It is also predicted in our study that E2 binding may impact the channel through two distinct mechanisms. The first mechanism involves a high&#x02010;affinity binding site that is located near the pore loop region, which is involved channel kinetics and plays an important role in normal physiology. Post&#x02010;adolescent females show more than nine times the number of arousal&#x02010;triggered arrhythmias than men of the same age group, and arousal&#x02010;triggered events are more than twice as high among female patients exhibiting mutations in the pore loop region of hERG, but not mutations in other regions (Kim <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0046" ref-type="ref">2010</xref>). We hypothesized that pore loop mutations may modify the oestrogen interaction with hERG. Indeed, this notion is corroborated by our findings, which suggest that E2 binds with higher affinity in the hERG model with the pore loop G604S mutation.</p><p>The second mechanism involves another high&#x02010;affinity binding site for E2, located in the intracellular cavity of hERG in the vicinity of Y652, a residue crucial for the channel block. This suggests that E2 may enhance the action of common blockers, such as dofetilide, as predicted by our binding enthalpy calculations. It is also probable that the mechanisms co&#x02010;exist, depending on the physiologically driven concentration fluctuations of E2 in cell membranes. Establishing a connection between these two mechanisms of action is a goal for our future studies.</p><p>The present study focuses on the role that changes in sympathetic tone play in triggering arousal&#x02010;induced arrhythmia. It should be noted that there are also sex&#x02010;related differences in parasympathetic tone that we have not considered in this study. It has been demonstrated that parasympathetic influence on cardiac function is greater in females than males (Dart <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0013" ref-type="ref">2002</xref>). Elevated parasympathetic tone, which is associated with greater heart rate variability, was found to be greater in premenopausal women and postmenopausal women receiving hormone replacement therapy, suggesting that oestrogen may be responsible (Liu <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0056" ref-type="ref">2003</xref>). Because of this, it is conceivable that abrupt termination of parasympathetic input also contributes to arousal&#x02010;induced arrhythmias, since vagal withdrawal has been shown to result in an increase in cAMP production that potentiates sympathetic responses (Belevych <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0005" ref-type="ref">2001</xref>; Harvey &#x00026; Belevych, <xref rid="tjp12403-bib-0035" ref-type="ref">2003</xref>).</p><sec id="tjp12403-sec-0290"><title>Limitations of the current study</title><p>There are several limitations in our study. While the O'Hara&#x02013;Rudy model was extensively validated in reproducing experimentally observed rate dependence in single cells, the model overestimates the rate dependence of APD in human tissue compared to experiments reported by Franz <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0027" ref-type="ref">1988</xref>). We also did not consider the presence of other prevalent disease states such as diabetes that have a sex difference component (Shimoni <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0086" ref-type="ref">2009</xref>).</p><p>An important limitation in the interpretation of structural modes of E2 binding to hERG is an absence of a high&#x02010;resolution experimental structure of the channel. In this study, we resorted to using homology models in our simulations, which depend on the availability of high&#x02010;resolution experimental template structures, in the desired conformational state, and with high sequence identity. We therefore chose suitable templates (Eag1 and Kv1.2) for our models that allowed us to study two distinct regions of interest in hERG: the pore loop region and the intracellular cavity. While we recognize the inherent limitations of using homology models, there is, importantly, remarkable consensus for crucial drug binding sites in both models that we used.</p><p>We also acknowledge that our molecular simulation approach returns only binding enthalpy distributions, which, in the absence of the entropic and diffusion data that are crucial for quantitative drug&#x02013;channel thermodynamic and kinetic predictions, are not able to unambiguously predict quantitative indices of current inhibition. We are planning further studies now with mapping free energy and diffusion profiles to compute &#x02018;on&#x02019; and &#x02018;off&#x02019; channel&#x02010;hormone interaction rates for the kinetic models to evaluate impact of hormone binding on the channel current blockade. Our current study reveals the first mechanistic models of how E2 could potentially enhance hERG blockade. However, dofetilide is known to exhibit several modes of binding to hERG and our first simulation here suggests that oestradiol helps to stabilize one of them in the open pore of the hERG channel. Furthermore, based on work of Sanguinetti (Chen <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0012" ref-type="ref">2002</xref>) and studies that followed (Rodriguez&#x02010;Menchaca <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0083" ref-type="ref">2006</xref>; Stork <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0091" ref-type="ref">2007</xref>; Lees&#x02010;Miller <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0054" ref-type="ref">2015</xref>), we may expect a state&#x02010;dependent blockade by dofetilide and thus will need to evaluate binding of a hormone to different states. Whether these are separate mechanisms or ones that can coexist are the questions we intend to study in the near future. This work will refine different E2 binding modes, their affinities and kinetics through a combination of experimental and computational studies.</p><p>The computational modelling and simulation approach has allowed us to explore the complex non&#x02010;linear interplay between processes that underlie differences in risk to acquired long&#x02010;QT&#x02010;dependent arrhythmias. They also allow us to predict the &#x02018;perfect storm&#x02019; of hormone concentration, <italic>I</italic>
<sub>Kr</sub> derangement and sympathetic stimulation that may explain one mechanism of increased proclivity to arousal arrhythmia in females. The results of this study suggest specific therapeutic anti&#x02010;arrhythmic strategies for women with long&#x02010;QT syndrome, which may include specific hormone replacement therapy, as well as suggested and counter&#x02010;indicated drugs. To realize the most basic biological mechanisms underlying sex&#x02010;based differences in long&#x02010;QT syndrome risk and susceptibility to TdP arrhythmias is the critical first step to set the stage for specific sex&#x02010;based diagnosis and therapeutic targeting of cardiac disease.</p></sec></sec><sec id="tjp12403-sec-0310"><title>Additional information</title><sec id="tjp12403-sec-0320"><title>Competing interests</title><p>None.</p></sec><sec id="tjp12403-sec-0330"><title>Author contributions</title><p>P.&#x02010;C.Y., L.L.P., and S.N. designed and performed simulations, analysed data, and prepared the manuscript; Y.W. and M.&#x02010;T.J. designed and performed simulations; F.L&#x02010;R. and J.K. designed and performed experiments; K.R.D. and I.V. analysed data, and revised the manuscript; R.D.H drafted the manuscript; C.E.C. designed simulations and experiments, analysed data, coordinated and oversaw the project, and prepared the manuscript. All authors approved the final submitted version.</p></sec><sec id="tjp12403-sec-0340"><title>Funding</title><p>American Heart Association (GIAs (13GRNT14370019), Western States Affiliate), the National Institutes of Health NHLBI R01HL128170&#x02010;02 (to CEC), NHLBI U01HL126273&#x02010;02 (CEC and RDH), National Institutes of Health R01GM101928&#x02010;01 (to RDH and CEC) and R01HL128537&#x02010;01A1 (to CEC, RDH and SYN), Canadian Institutes for Health Research (MOP&#x02010;186232) and Heart and Stroke Foundation, Alberta (GIA) (to SYN). American Heart Association Predoctoral Fellowship 16PRE27260295 (to KRD). Japan AMED16mk0104027h1102, AMED16mk0104007h9903, MEXT/JSPS KAKENHI 15H04684 (to JK).</p></sec></sec></body><back><ref-list id="tjp12403-bibl-0001"><title>References</title><ref id="tjp12403-bib-0001"><mixed-citation publication-type="journal" id="tjp12403-cit-0001">
<string-name>
<surname>Anneken</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Baumann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vigneault</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Biliczki</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Friedrich</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Girmatsion</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Takac</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Brandes</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Kissler</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wiegratz</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Zumhagen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Stallmeyer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hohnloser</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Klingenheben</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schulze&#x02010;Bahr</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nattel</surname>
<given-names>S</given-names>
</string-name> &#x00026; <string-name>
<surname>Ehrlich</surname>
<given-names>JR</given-names>
</string-name> (<year>2016</year>). <article-title>Estradiol regulates human QT&#x02010;interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking</article-title>. <source>Eur Heart J</source>
<volume>37</volume>, <fpage>640</fpage>&#x02013;<lpage>650</lpage>.<pub-id pub-id-type="pmid">26271031</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0002"><mixed-citation publication-type="journal" id="tjp12403-cit-0002">
<string-name>
<surname>Anwar&#x02010;Mohamed</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Barakat</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Bhat</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Tyrrell</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Tuszynski</surname>
<given-names>JA</given-names>
</string-name> &#x00026; <string-name>
<surname>Houghton</surname>
<given-names>M</given-names>
</string-name> (<year>2014</year>). <article-title>A human ether&#x02010;&#x000e1;&#x02010;go&#x02010;go&#x02010;related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity</article-title>. <source>Toxicol Lett</source>
<volume>230</volume>, <fpage>382</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">25127758</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0003"><mixed-citation publication-type="journal" id="tjp12403-cit-0003">
<string-name>
<surname>Bai</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tamagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> (<year>2005</year>). <article-title>Nontranscriptional regulation of cardiac repolarization currents by testosterone</article-title>. <source>Circulation</source>
<volume>112</volume>, <fpage>1701</fpage>&#x02013;<lpage>1710</lpage>.<pub-id pub-id-type="pmid">16157773</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0004"><mixed-citation publication-type="journal" id="tjp12403-cit-0004">
<string-name>
<surname>Bazett</surname>
<given-names>HC</given-names>
</string-name> (<year>1997</year>). <article-title>An analysis of the time&#x02010;relations of electrocardiograms</article-title>. <source>Ann Noninvasive Electrocardiol</source>
<volume>2</volume>, <fpage>177</fpage>&#x02013;<lpage>194</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0005"><mixed-citation publication-type="journal" id="tjp12403-cit-0005">
<string-name>
<surname>Belevych</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Sims</surname>
<given-names>C</given-names>
</string-name> &#x00026; <string-name>
<surname>Harvey</surname>
<given-names>RD</given-names>
</string-name> (<year>2001</year>). <article-title>ACh&#x02010;induced rebound stimulation of L&#x02010;type Ca<sup>2+</sup> current in guinea&#x02010;pig ventricular myocytes, mediated by G&#x003b2;&#x003b3;&#x02010;dependent activation of adenylyl cyclase</article-title>. <source>J Physiol</source>
<volume>536</volume>, <fpage>677</fpage>&#x02013;<lpage>692</lpage>.<pub-id pub-id-type="pmid">11691864</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0006"><mixed-citation publication-type="journal" id="tjp12403-cit-0006">
<string-name>
<surname>Benkert</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Biasini</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Schwede</surname>
<given-names>T</given-names>
</string-name> (<year>2011</year>). <article-title>Toward the estimation of the absolute quality of individual protein structure models</article-title>. <source>Bioinformatics</source>
<volume>27</volume>, <fpage>343</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">21134891</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0007"><mixed-citation publication-type="journal" id="tjp12403-cit-0007">
<string-name>
<surname>Best</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lopes</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Mittal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Feig</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Mackerell</surname>
<given-names>AD</given-names>
<suffix>Jr</suffix>
</string-name> (<year>2012</year>). <article-title>Optimization of the additive CHARMM all&#x02010;atom protein force field targeting improved sampling of the backbone &#x003d5;, &#x003c8; &#x000a0;and side&#x02010;chain &#x003c7;<sub>1</sub> and &#x003c7;<sub>2</sub> dihedral angles</article-title>. <source>J&#x000a0;Chem Theory Comput</source>
<volume>8</volume>, <fpage>3257</fpage>&#x02013;<lpage>3273</lpage>.<pub-id pub-id-type="pmid">23341755</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0008"><mixed-citation publication-type="journal" id="tjp12403-cit-0008">
<string-name>
<surname>Bidoggia</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Maciel</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Capalozza</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mosca</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blaksley</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Valverde</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bertran</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Arini</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Biagetti</surname>
<given-names>MO</given-names>
</string-name> &#x00026; <string-name>
<surname>Quinteiro</surname>
<given-names>RA</given-names>
</string-name> (<year>2000</year>). <article-title>Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone</article-title>. <source>Am Heart J</source>
<volume>140</volume>, <fpage>678</fpage>&#x02013;<lpage>683</lpage>.<pub-id pub-id-type="pmid">11011345</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0009"><mixed-citation publication-type="journal" id="tjp12403-cit-0009">
<string-name>
<surname>Brini</surname>
<given-names>M</given-names>
</string-name> (<year>2009</year>). <article-title>Plasma membrane Ca<sup>2+</sup>&#x02010;ATPase: from a housekeeping function to a versatile signalling role</article-title>. <source>Pflugers Archiv</source>
<volume>457</volume>, <fpage>657</fpage>&#x02013;<lpage>664</lpage>.<pub-id pub-id-type="pmid">18548270</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0010"><mixed-citation publication-type="journal" id="tjp12403-cit-0010">
<string-name>
<surname>Burke</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Ehlert</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Kruse</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Goldberger</surname>
<given-names>JJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Kadish</surname>
<given-names>AH</given-names>
</string-name> (<year>1997</year>). <article-title>Gender&#x02010;specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults</article-title>. <source>Am J Cardiol</source>
<volume>79</volume>, <fpage>178</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">9193019</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0011"><mixed-citation publication-type="journal" id="tjp12403-cit-0011">
<string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Alber</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shusterman</surname>
<given-names>V</given-names>
</string-name> &#x00026; <string-name>
<surname>Salama</surname>
<given-names>G</given-names>
</string-name> (<year>2011</year>). <article-title>Regional genomic regulation of cardiac sodium&#x02010;calcium exchanger by oestrogen</article-title>. <source>J Physiol</source>
<volume>589</volume>, <fpage>1061</fpage>&#x02013;<lpage>1080</lpage>.<pub-id pub-id-type="pmid">21224239</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0012"><mixed-citation publication-type="journal" id="tjp12403-cit-0012">
<string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Seebohm</surname>
<given-names>G</given-names>
</string-name> &#x00026; <string-name>
<surname>Sanguinetti</surname>
<given-names>MC</given-names>
</string-name> (<year>2002</year>). <article-title>Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>99</volume>, <fpage>12461</fpage>&#x02013;<lpage>12466</lpage>.<pub-id pub-id-type="pmid">12209010</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0013"><mixed-citation publication-type="journal" id="tjp12403-cit-0013">
<string-name>
<surname>Dart</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>XJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Kingwell</surname>
<given-names>BA</given-names>
</string-name> (<year>2002</year>). <article-title>Gender, sex hormones and autonomic nervous control of the cardiovascular system</article-title>. <source>Cardiovasc Res</source>
<volume>53</volume>, <fpage>678</fpage>&#x02013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">11861039</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0014"><mixed-citation publication-type="journal" id="tjp12403-cit-0014">
<string-name>
<surname>Demolis</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Funck&#x02010;Brentano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ropers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ghadanfar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nichols</surname>
<given-names>DJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Jaillon</surname>
<given-names>P</given-names>
</string-name> (<year>1996</year>). <article-title>Influence of dofetilide on QT&#x02010;interval duration and dispersion at various heart rates during exercise in humans</article-title>. <source>Circulation</source>
<volume>94</volume>, <fpage>1592</fpage>&#x02013;<lpage>1599</lpage>.<pub-id pub-id-type="pmid">8840849</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0015"><mixed-citation publication-type="journal" id="tjp12403-cit-0015">
<string-name>
<surname>Dhamoon</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Pandit</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Sarmast</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Parisian</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Guha</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bagwe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taffet</surname>
<given-names>SM</given-names>
</string-name> &#x00026; <string-name>
<surname>Anumonwo</surname>
<given-names>JM</given-names>
</string-name> (<year>2004</year>). <article-title>Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K<sup>+</sup> current</article-title>. <source>Circ Res</source>
<volume>94</volume>, <fpage>1332</fpage>&#x02013;<lpage>1339</lpage>.<pub-id pub-id-type="pmid">15087421</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0016"><mixed-citation publication-type="journal" id="tjp12403-cit-0016">
<string-name>
<surname>Dighe</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Moy</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>FJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Sluss</surname>
<given-names>PM</given-names>
</string-name> (<year>2005</year>). <article-title>High&#x02010;resolution reference ranges for estradiol, luteinizing hormone, and follicle&#x02010;stimulating hormone in men and women using the AxSYM assay system</article-title>. <source>Clin Biochem</source>
<volume>38</volume>, <fpage>175</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">15642281</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0017"><mixed-citation publication-type="journal" id="tjp12403-cit-0017">
<string-name>
<surname>Dorgan</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Fears</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Aronson Friedman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Patterson</surname>
<given-names>BH</given-names>
</string-name> &#x00026; <string-name>
<surname>Greenhut</surname>
<given-names>SF</given-names>
</string-name> (<year>2002</year>). <article-title>Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry</article-title>. <source>Steroids</source>
<volume>67</volume>, <fpage>151</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">11856538</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0018"><mixed-citation publication-type="journal" id="tjp12403-cit-0018">
<string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>ZP</given-names>
</string-name> &#x00026; <string-name>
<surname>Sheldon</surname>
<given-names>RS</given-names>
</string-name> (<year>1995</year>). <article-title>High&#x02010; and low&#x02010;affinity sites for [<sup>3</sup>H]dofetilide binding to guinea pig myocytes</article-title>. <source>Circ Res</source>
<volume>77</volume>, <fpage>718</fpage>&#x02013;<lpage>725</lpage>.<pub-id pub-id-type="pmid">7554118</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0019"><mixed-citation publication-type="journal" id="tjp12403-cit-0019">
<string-name>
<surname>Durdagi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Deshpande</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> (<year>2012</year>). <article-title>Modeling of open, closed, and open&#x02010;inactivated states of the hERG1 channel: structural mechanisms of the state&#x02010;dependent drug binding</article-title>. <source>J Chem Inf Model</source>
<volume>52</volume>, <fpage>2760</fpage>&#x02013;<lpage>2774</lpage>.<pub-id pub-id-type="pmid">22989185</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0020"><mixed-citation publication-type="journal" id="tjp12403-cit-0020">
<string-name>
<surname>Durdagi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> (<year>2011</year>). <article-title>Combined receptor and ligand&#x02010;based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain</article-title>. <source>J Chem Inf Model</source>
<volume>51</volume>, <fpage>463</fpage>&#x02013;<lpage>474</lpage>.<pub-id pub-id-type="pmid">21241063</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0021"><mixed-citation publication-type="journal" id="tjp12403-cit-0021">
<string-name>
<surname>Durdagi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Subbotina</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lees&#x02010;Miller</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> (<year>2010</year>). <article-title>Insights into the molecular mechanism of hERG1 channel activation and blockade by drugs</article-title>. <source>Curr Med Chem</source>
<volume>17</volume>, <fpage>3514</fpage>&#x02013;<lpage>3532</lpage>.<pub-id pub-id-type="pmid">20738248</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0022"><mixed-citation publication-type="journal" id="tjp12403-cit-0022">
<string-name>
<surname>Ebert</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>XK</given-names>
</string-name> &#x00026; <string-name>
<surname>Woosley</surname>
<given-names>RL</given-names>
</string-name> (<year>1998</year>). <article-title>Female gender as a risk factor for drug&#x02010;induced cardiac arrhythmias: evaluation of clinical and experimental evidence</article-title>. <source>J Womens Health</source>
<volume>7</volume>, <fpage>547</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">9650155</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0023"><mixed-citation publication-type="journal" id="tjp12403-cit-0023">
<string-name>
<surname>Essmann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Berkowitz</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Darden</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Pedersen</surname>
<given-names>LG</given-names>
</string-name> (<year>1995</year>). <article-title>A smooth particle mesh ewald method</article-title>. <source>J Chem Phys</source>
<volume>103</volume>, <fpage>8577</fpage>&#x02013;<lpage>8593</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0024"><mixed-citation publication-type="journal" id="tjp12403-cit-0024">
<string-name>
<surname>Faber</surname>
<given-names>GM</given-names>
</string-name> &#x00026; <string-name>
<surname>Rudy</surname>
<given-names>Y</given-names>
</string-name> (<year>2000</year>). <article-title>Action potential and contractility changes in [Na<sup>+</sup>]<sub>i</sub> overloaded cardiac myocytes: a simulation study</article-title>. <source>Biophys J</source>
<volume>78</volume>, <fpage>2392</fpage>&#x02013;<lpage>2404</lpage>.<pub-id pub-id-type="pmid">10777735</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0025"><mixed-citation publication-type="journal" id="tjp12403-cit-0025">
<string-name>
<surname>Fernandez</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ghanta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kauffman</surname>
<given-names>GW</given-names>
</string-name> &#x00026; <string-name>
<surname>Sanguinetti</surname>
<given-names>MC</given-names>
</string-name> (<year>2004</year>). <article-title>Physicochemical features of the HERG channel drug binding site</article-title>. <source>J Biol Chem</source>
<volume>279</volume>, <fpage>10120</fpage>&#x02013;<lpage>10127</lpage>.<pub-id pub-id-type="pmid">14699101</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0026"><mixed-citation publication-type="journal" id="tjp12403-cit-0026">
<string-name>
<surname>Ficker</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jarolimek</surname>
<given-names>W</given-names>
</string-name> &#x00026; <string-name>
<surname>Brown</surname>
<given-names>AM</given-names>
</string-name> (<year>2001</year>). <article-title>Molecular determinants of inactivation and dofetilide block in <italic>ether a&#x02010;go&#x02010;go</italic> (EAG) channels and EAG&#x02010;related K<sup>+</sup> channels</article-title>. <source>Mol Pharmacol</source>
<volume>60</volume>, <fpage>1343</fpage>&#x02013;<lpage>1348</lpage>.<pub-id pub-id-type="pmid">11723241</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0027"><mixed-citation publication-type="journal" id="tjp12403-cit-0027">
<string-name>
<surname>Franz</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Swerdlow</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Liem</surname>
<given-names>LB</given-names>
</string-name> &#x00026; <string-name>
<surname>Schaefer</surname>
<given-names>J</given-names>
</string-name> (<year>1988</year>). <article-title>Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady&#x02010;state frequencies</article-title>. <source>J Clin Invest</source>
<volume>82</volume>, <fpage>972</fpage>&#x02013;<lpage>979</lpage>.<pub-id pub-id-type="pmid">3417875</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0028"><mixed-citation publication-type="journal" id="tjp12403-cit-0028">
<string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> &#x00026; <string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name> (<year>2007</year>). <article-title>Regulation of cardiac ion channels via non&#x02010;genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias</article-title>. <source>Pharmacol Ther</source>
<volume>115</volume>, <fpage>106</fpage>&#x02013;<lpage>115</lpage>.<pub-id pub-id-type="pmid">17583354</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0029"><mixed-citation publication-type="journal" id="tjp12403-cit-0029">
<string-name>
<surname>Gaborit</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Le Bouter</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Szuts</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Varro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Escande</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nattel</surname>
<given-names>S</given-names>
</string-name> &#x00026; <string-name>
<surname>Demolombe</surname>
<given-names>S</given-names>
</string-name> (<year>2007</year>). <article-title>Regional and tissue specific transcript signatures of ion channel genes in the non&#x02010;diseased human heart</article-title>. <source>J Physiol</source>
<volume>582</volume>, <fpage>675</fpage>&#x02013;<lpage>693</lpage>.<pub-id pub-id-type="pmid">17478540</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0030"><mixed-citation publication-type="journal" id="tjp12403-cit-0030">
<string-name>
<surname>Gaborit</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Varro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Le Bouter</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Szuts</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Escande</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nattel</surname>
<given-names>S</given-names>
</string-name> &#x00026; <string-name>
<surname>Demolombe</surname>
<given-names>S</given-names>
</string-name> (<year>2010</year>). <article-title>Gender&#x02010;related differences in ion&#x02010;channel and transporter subunit expression in non&#x02010;diseased human hearts</article-title>. <source>J Mol Cell Cardiol</source>
<volume>49</volume>, <fpage>639</fpage>&#x02013;<lpage>646</lpage>.<pub-id pub-id-type="pmid">20600101</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0031"><mixed-citation publication-type="journal" id="tjp12403-cit-0031">
<string-name>
<surname>Gabrielsen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ravna</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Kristiansen</surname>
<given-names>K</given-names>
</string-name> &#x00026; <string-name>
<surname>Sylte</surname>
<given-names>I</given-names>
</string-name> (<year>2012</year>). <article-title>Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations</article-title>. <source>J Mol Model</source>
<volume>18</volume>, <fpage>1073</fpage>&#x02013;<lpage>1085</lpage>.<pub-id pub-id-type="pmid">21670993</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0032"><mixed-citation publication-type="journal" id="tjp12403-cit-0032">
<string-name>
<surname>Gima</surname>
<given-names>K</given-names>
</string-name> &#x00026; <string-name>
<surname>Rudy</surname>
<given-names>Y</given-names>
</string-name> (<year>2002</year>). <article-title>Ionic current basis of electrocardiographic waveforms: a model study</article-title>. <source>Circ Res</source>
<volume>90</volume>, <fpage>889</fpage>&#x02013;<lpage>896</lpage>.<pub-id pub-id-type="pmid">11988490</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0033"><mixed-citation publication-type="journal" id="tjp12403-cit-0033">
<string-name>
<surname>Glukhov</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Fedorov</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ravikumar</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>Kalish</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Schuessler</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Moazami</surname>
<given-names>N</given-names>
</string-name> &#x00026; <string-name>
<surname>Efimov</surname>
<given-names>IR</given-names>
</string-name> (<year>2010</year>). <article-title>Transmural dispersion of repolarization in failing and nonfailing human ventricle</article-title>. <source>Circ Res</source>
<volume>106</volume>, <fpage>981</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">20093630</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0034"><mixed-citation publication-type="journal" id="tjp12403-cit-0034">
<string-name>
<surname>Grundy</surname>
<given-names>D</given-names>
</string-name> (<year>2015</year>). <article-title>Principles and standards for reporting animal experiments in the journal of physiology and experimental physiology</article-title>. <source>J Physiol</source>
<volume>593</volume>, <fpage>2547</fpage>&#x02013;<lpage>2549</lpage>.<pub-id pub-id-type="pmid">26095019</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0035"><mixed-citation publication-type="journal" id="tjp12403-cit-0035">
<string-name>
<surname>Harvey</surname>
<given-names>RD</given-names>
</string-name> &#x00026; <string-name>
<surname>Belevych</surname>
<given-names>AE</given-names>
</string-name> (<year>2003</year>). <article-title>Muscarinic regulation of cardiac ion channels</article-title>. <source>Br J Pharmacol</source>
<volume>139</volume>, <fpage>1074</fpage>&#x02013;<lpage>1084</lpage>.<pub-id pub-id-type="pmid">12871825</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0036"><mixed-citation publication-type="journal" id="tjp12403-cit-0036">
<string-name>
<surname>Hoeker</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Hood</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Katra</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Poelzing</surname>
<given-names>S</given-names>
</string-name> &#x00026; <string-name>
<surname>Pogwizd</surname>
<given-names>SM</given-names>
</string-name> (<year>2014</year>). <article-title>Sex differences in beta&#x02010;adrenergic responsiveness of action potentials and intracellular calcium handling in isolated rabbit hearts</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e111411</fpage>.<pub-id pub-id-type="pmid">25340795</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0037"><mixed-citation publication-type="journal" id="tjp12403-cit-0037">
<string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name> &#x00026; <string-name>
<surname>Roux</surname>
<given-names>B</given-names>
</string-name> (<year>2013</year>). <article-title>Automated force field parameterization for nonpolarizable and polarizable models based on ab initio target data</article-title>. <source>J Chem Theory Comput</source>
<volume>9</volume>, <fpage>3543</fpage>&#x02013;<lpage>3556</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0038"><mixed-citation publication-type="journal" id="tjp12403-cit-0038">
<string-name>
<surname>Huikuri</surname>
<given-names>HV</given-names>
</string-name>, <string-name>
<surname>Pikkujamsa</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Airaksinen</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Ikaheimo</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Rantala</surname>
<given-names>AO</given-names>
</string-name>, <string-name>
<surname>Kauma</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lilja</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Kesaniemi</surname>
<given-names>YA</given-names>
</string-name> (<year>1996</year>). <article-title>Sex&#x02010;related differences in autonomic modulation of heart rate in middle&#x02010;aged subjects</article-title>. <source>Circulation</source>
<volume>94</volume>, <fpage>122</fpage>&#x02013;<lpage>125</lpage>.<pub-id pub-id-type="pmid">8674168</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0039"><mixed-citation publication-type="journal" id="tjp12403-cit-0039">
<string-name>
<surname>Huo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Grace</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>CL</given-names>
</string-name> &#x00026; <string-name>
<surname>Ma</surname>
<given-names>A</given-names>
</string-name> (<year>2008</year>). <article-title>The G604S&#x02010;hERG mutation alters the biophysical properties and exerts a dominant&#x02010;negative effect on expression of hERG channels in HEK293 cells</article-title>. <source>Pflugers Archiv</source>
<volume>456</volume>, <fpage>917</fpage>&#x02013;<lpage>928</lpage>.<pub-id pub-id-type="pmid">18386051</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0040"><mixed-citation publication-type="journal" id="tjp12403-cit-0040">
<string-name>
<surname>Irwin</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sterling</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mysinger</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Bolstad</surname>
<given-names>ES</given-names>
</string-name> &#x00026; <string-name>
<surname>Coleman</surname>
<given-names>RG</given-names>
</string-name> (<year>2012</year>). <article-title>ZINC: a free tool to discover chemistry for biology</article-title>. <source>J&#x000a0;Chem Inf Model</source>
<volume>52</volume>, <fpage>1757</fpage>&#x02013;<lpage>1768</lpage>.<pub-id pub-id-type="pmid">22587354</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0041"><mixed-citation publication-type="journal" id="tjp12403-cit-0041">
<string-name>
<surname>James</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Choisy</surname>
<given-names>SCM</given-names>
</string-name> &#x00026; <string-name>
<surname>Hancox</surname>
<given-names>JC</given-names>
</string-name> (<year>2007</year>). <article-title>Recent advances in understanding sex differences in cardiac repolarization</article-title>. <source>Prog Biophys Mol Biol</source>
<volume>94</volume>, <fpage>265</fpage>&#x02013;<lpage>319</lpage>.<pub-id pub-id-type="pmid">15979693</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0042"><mixed-citation publication-type="journal" id="tjp12403-cit-0042">
<string-name>
<surname>Janse de Jonge</surname>
<given-names>XA</given-names>
</string-name>, <string-name>
<surname>Boot</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Thom</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Ruell</surname>
<given-names>PA</given-names>
</string-name> &#x00026; <string-name>
<surname>Thompson</surname>
<given-names>MW</given-names>
</string-name> (<year>2001</year>). <article-title>The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans</article-title>. <source>J&#x000a0;Physiol</source>
<volume>530</volume>, <fpage>161</fpage>&#x02013;<lpage>166</lpage>.<pub-id pub-id-type="pmid">11136868</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0043"><mixed-citation publication-type="journal" id="tjp12403-cit-0043">
<string-name>
<surname>Jo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iyer</surname>
<given-names>VG</given-names>
</string-name> &#x00026; <string-name>
<surname>Im</surname>
<given-names>W</given-names>
</string-name> (<year>2008</year>). <article-title>CHARMM&#x02010;GUI: a web&#x02010;based graphical user interface for CHARMM</article-title>. <source>J Comput Chem</source>
<volume>29</volume>, <fpage>1859</fpage>&#x02013;<lpage>1865</lpage>.<pub-id pub-id-type="pmid">18351591</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0044"><mixed-citation publication-type="journal" id="tjp12403-cit-0044">
<string-name>
<surname>Jorgensen</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Chandrasekhar</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Madura</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Impey</surname>
<given-names>RW</given-names>
</string-name> &#x00026; <string-name>
<surname>Klein</surname>
<given-names>ML</given-names>
</string-name> (<year>1983</year>). <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source>J Chem Phys</source>
<volume>79</volume>, <fpage>926</fpage>&#x02013;<lpage>935</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0045"><mixed-citation publication-type="journal" id="tjp12403-cit-0045">
<string-name>
<surname>Jose</surname>
<given-names>AD</given-names>
</string-name> &#x00026; <string-name>
<surname>Collison</surname>
<given-names>D</given-names>
</string-name> (<year>1970</year>). <article-title>The normal range and determinants of the intrinsic heart rate in man</article-title>. <source>Cardiovasc Res</source>
<volume>4</volume>, <fpage>160</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">4192616</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0046"><mixed-citation publication-type="journal" id="tjp12403-cit-0046">
<string-name>
<surname>Kim</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Lopes</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Moss</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>McNitt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Barsheshet</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Zareba</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ackerman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Kaufman</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Towbin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Goldenberg</surname>
<given-names>I</given-names>
</string-name> (<year>2010</year>). <article-title>Trigger&#x02010;specific risk factors and response to therapy in long QT syndrome type 2</article-title>. <source>Heart Rhythm</source>
<volume>7</volume>, <fpage>1797</fpage>&#x02013;<lpage>1805</lpage>.<pub-id pub-id-type="pmid">20850565</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0047"><mixed-citation publication-type="journal" id="tjp12403-cit-0047">
<string-name>
<surname>Klauda</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Venable</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Freites</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>O'Connor</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Tobias</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Mondragon&#x02010;Ramirez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vorobyov</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>MacKerell</surname>
<given-names>AD</given-names>
<suffix>Jr</suffix>
</string-name> &#x00026; <string-name>
<surname>Pastor</surname>
<given-names>RW</given-names>
</string-name> (<year>2010</year>). <article-title>Update of the CHARMM all&#x02010;atom additive force field for lipids: validation on six lipid types</article-title>. <source>J&#x000a0;Phys Chem B</source>
<volume>114</volume>, <fpage>7830</fpage>&#x02013;<lpage>7843</lpage>.<pub-id pub-id-type="pmid">20496934</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0048"><mixed-citation publication-type="journal" id="tjp12403-cit-0048">
<string-name>
<surname>Kopp</surname>
<given-names>J</given-names>
</string-name> &#x00026; <string-name>
<surname>Schwede</surname>
<given-names>T</given-names>
</string-name> (<year>2004</year>). <article-title>The SWISS&#x02010;MODEL Repository of annotated three&#x02010;dimensional protein structure homology models</article-title>. <source>Nucleic Acids Res</source>
<volume>32</volume>, <fpage>D230</fpage>&#x02013;<lpage>D234</lpage>.<pub-id pub-id-type="pmid">14681401</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0049"><mixed-citation publication-type="journal" id="tjp12403-cit-0049">
<string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sasano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kodama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ebana</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Honda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> (<year>2015</year>). <article-title>Aromatase knockout mice reveal an impact of estrogen on drug&#x02010;induced alternation of murine electrocardiography parameters</article-title>. <source>J Toxicol Sci</source>
<volume>40</volume>, <fpage>339</fpage>&#x02013;<lpage>348</lpage>.<pub-id pub-id-type="pmid">25972195</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0050"><mixed-citation publication-type="journal" id="tjp12403-cit-0050">
<string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name> &#x00026; <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> (<year>2009</year>). <article-title>New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: acute effects of female hormones on cardiac ion channels and cardiac repolarization</article-title>. <source>J Pharmacol Sci</source>
<volume>109</volume>, <fpage>334</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">19270425</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0051"><mixed-citation publication-type="journal" id="tjp12403-cit-0051">
<string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tamagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Honda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Nakaya</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> (<year>2008</year>). <article-title>Acute effects of oestrogen on the guinea pig and human IKr channels and drug&#x02010;induced prolongation of cardiac repolarization</article-title>. <source>J Physiol</source>
<volume>586</volume>, <fpage>2961</fpage>&#x02013;<lpage>2973</lpage>.<pub-id pub-id-type="pmid">18440994</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0052"><mixed-citation publication-type="journal" id="tjp12403-cit-0052">
<string-name>
<surname>Lanfranchi</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Ackerman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Kara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shamsuzzaman</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Wolk</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jurak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Amin</surname>
<given-names>R</given-names>
</string-name> &#x00026; <string-name>
<surname>Somers</surname>
<given-names>VK</given-names>
</string-name> (<year>2010</year>). <article-title>Gene&#x02010;specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome</article-title>. <source>Heart Rhythm</source>
<volume>7</volume>, <fpage>1067</fpage>&#x02013;<lpage>1074</lpage>.<pub-id pub-id-type="pmid">20470906</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0053"><mixed-citation publication-type="journal" id="tjp12403-cit-0053">
<string-name>
<surname>Lees&#x02010;Miller</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>GQ</given-names>
</string-name> &#x00026; <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> (<year>2000</year>). <article-title>Molecular determinant of high&#x02010;affinity dofetilide binding to <italic>HERG1</italic> expressed in <italic>Xenopus</italic> oocytes: involvement of S6 sites</article-title>. <source>Mol Pharmacol</source>
<volume>57</volume>, <fpage>367</fpage>&#x02013;<lpage>374</lpage>.<pub-id pub-id-type="pmid">10648647</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0054"><mixed-citation publication-type="journal" id="tjp12403-cit-0054">
<string-name>
<surname>Lees&#x02010;Miller</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Perissinotti</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> &#x00026; <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> (<year>2015</year>). <article-title>Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration&#x02010;range overlapping with that required to block HCN4</article-title>. <source>J Mol Cell Cardiol</source>
<volume>85</volume>, <fpage>71</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">25986146</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0055"><mixed-citation publication-type="journal" id="tjp12403-cit-0055">
<string-name>
<surname>Lehmann</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Archibald</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Quart</surname>
<given-names>B</given-names>
</string-name> &#x00026; <string-name>
<surname>MacNeil</surname>
<given-names>DJ</given-names>
</string-name> (<year>1996</year>). <article-title>Sex difference in risk of torsade de pointes with d,l&#x02010;sotalol</article-title>. <source>Circulation</source>
<volume>94</volume>, <fpage>2535</fpage>&#x02013;<lpage>2541</lpage>.<pub-id pub-id-type="pmid">8921798</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0056"><mixed-citation publication-type="journal" id="tjp12403-cit-0056">
<string-name>
<surname>Liu</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>TB</given-names>
</string-name> &#x00026; <string-name>
<surname>Yang</surname>
<given-names>CC</given-names>
</string-name> (<year>2003</year>). <article-title>Effects of estrogen on gender&#x02010;related autonomic differences in humans</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>285</volume>, <fpage>H2188</fpage>&#x02013;<lpage>H2193</lpage>.<pub-id pub-id-type="pmid">12881217</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0057"><mixed-citation publication-type="journal" id="tjp12403-cit-0057">
<string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>B&#x02010;R</given-names>
</string-name>, <string-name>
<surname>Drici</surname>
<given-names>M&#x02010;D</given-names>
</string-name> &#x00026; <string-name>
<surname>Salama</surname>
<given-names>G</given-names>
</string-name> (<year>2005</year>). <article-title>Sex modulates the arrhythmogenic substrate in prepubertal rabbit hearts with Long QT 2</article-title>. <source>J Cardiovasc Electrophysiol</source>
<volume>16</volume>, <fpage>516</fpage>&#x02013;<lpage>524</lpage>.<pub-id pub-id-type="pmid">15877623</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0058"><mixed-citation publication-type="journal" id="tjp12403-cit-0058">
<string-name>
<surname>Locati</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Zareba</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Moss</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Lehmann</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Towbin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Priori</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Napolitano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Timothy</surname>
<given-names>K</given-names>
</string-name> &#x00026; <string-name>
<surname>Hall</surname>
<given-names>WJ</given-names>
</string-name> (<year>1998</year>). <article-title>Age&#x02010; and sex&#x02010;related differences in clinical manifestations in patients with congenital long&#x02010;QT syndrome: findings from the International LQTS Registry</article-title>. <source>Circulation</source>
<volume>97</volume>, <fpage>2237</fpage>&#x02013;<lpage>2244</lpage>.<pub-id pub-id-type="pmid">9631873</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0059"><mixed-citation publication-type="journal" id="tjp12403-cit-0059">
<string-name>
<surname>Lou</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Fedorov</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Glukhov</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Moazami</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fast</surname>
<given-names>VG</given-names>
</string-name> &#x00026; <string-name>
<surname>Efimov</surname>
<given-names>IR</given-names>
</string-name> (<year>2011</year>). <article-title>Transmural heterogeneity and remodeling of ventricular excitation&#x02010;contraction coupling in human heart failure</article-title>. <source>Circulation</source>
<volume>123</volume>, <fpage>1881</fpage>&#x02013;<lpage>1890</lpage>.<pub-id pub-id-type="pmid">21502574</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0060"><mixed-citation publication-type="journal" id="tjp12403-cit-0060">
<string-name>
<surname>MacKerell</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Bashford</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bellott</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dunbrack</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Evanseck</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Field</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Joseph&#x02010;McCarthy</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kuchnir</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kuczera</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>FTK</given-names>
</string-name>, <string-name>
<surname>Mattos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Michnick</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ngo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Prodhom</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reiher</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Roux</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schlenkrich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Stote</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Straub</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wiorkiewicz&#x02010;Kuczera</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>D</given-names>
</string-name> &#x00026; <string-name>
<surname>Karplus</surname>
<given-names>M</given-names>
</string-name> (<year>1998</year>). <article-title>All&#x02010;atom empirical potential for molecular modeling and dynamics studies of proteins</article-title>. <source>J Phys Chem B</source>
<volume>102</volume>, <fpage>3586</fpage>&#x02013;<lpage>3616</lpage>.<pub-id pub-id-type="pmid">24889800</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0061"><mixed-citation publication-type="journal" id="tjp12403-cit-0061">
<string-name>
<surname>Magnano</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Holleran</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ramakrishnan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Reiffel</surname>
<given-names>JA</given-names>
</string-name> &#x00026; <string-name>
<surname>Bloomfield</surname>
<given-names>DM</given-names>
</string-name> (<year>2002</year>). <article-title>Autonomic nervous system influences on QT interval in normal subjects</article-title>. <source>J Am Coll Cardiol</source>
<volume>39</volume>, <fpage>1820</fpage>&#x02013;<lpage>1826</lpage>.<pub-id pub-id-type="pmid">12039498</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0062"><mixed-citation publication-type="journal" id="tjp12403-cit-0062">
<string-name>
<surname>Makkar</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Fromm</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Steinman</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Meissner</surname>
<given-names>MD</given-names>
</string-name> &#x00026; <string-name>
<surname>Lehmann</surname>
<given-names>MH</given-names>
</string-name> (<year>1993</year>). <article-title>Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs</article-title>. <source>J&#x000a0;Am Med Assoc</source>
<volume>270</volume>, <fpage>2590</fpage>&#x02013;<lpage>2597</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0063"><mixed-citation publication-type="journal" id="tjp12403-cit-0063">
<string-name>
<surname>Mitcheson</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name> &#x00026; <string-name>
<surname>Sanguinetti</surname>
<given-names>MC</given-names>
</string-name> (<year>2000</year>). <article-title>Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate</article-title>. <source>J Gen Physiol</source>
<volume>115</volume>, <fpage>229</fpage>&#x02013;<lpage>240</lpage>.<pub-id pub-id-type="pmid">10694252</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0064"><mixed-citation publication-type="journal" id="tjp12403-cit-0064">
<string-name>
<surname>Moss</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Gessman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gillespie</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zareba</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Benhorin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Heilbron</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Towbin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Priori</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Napolitano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Medina</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>ML</given-names>
</string-name> &#x00026; <string-name>
<surname>Timothy</surname>
<given-names>K</given-names>
</string-name> (<year>1999</year>). <article-title>Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome</article-title>. <source>Am J Cardiol</source>
<volume>84</volume>, <fpage>876</fpage>&#x02013;<lpage>879</lpage>.<pub-id pub-id-type="pmid">10532503</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0065"><mixed-citation publication-type="journal" id="tjp12403-cit-0065">
<string-name>
<surname>Munro</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Stabenfeldt</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Cragun</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Addiego</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Overstreet</surname>
<given-names>JW</given-names>
</string-name> &#x00026; <string-name>
<surname>Lasley</surname>
<given-names>BL</given-names>
</string-name> (<year>1991</year>). <article-title>Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay</article-title>. <source>Clin Chem</source>
<volume>37</volume>, <fpage>838</fpage>&#x02013;<lpage>844</lpage>.<pub-id pub-id-type="pmid">2049848</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0066"><mixed-citation publication-type="journal" id="tjp12403-cit-0066">
<string-name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ooie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ou</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ichinose</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yonemochi</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Saikawa</surname>
<given-names>T</given-names>
</string-name> (<year>2005</year>). <article-title>Gender differences in autonomic modulation of ventricular repolarization in humans</article-title>. <source>J Cardiovasc Electrophysiol</source>
<volume>16</volume>, <fpage>278</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">15817086</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0067"><mixed-citation publication-type="journal" id="tjp12403-cit-0067">
<string-name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ooie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Taniguchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Anan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yonemochi</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Saikawa</surname>
<given-names>T</given-names>
</string-name> (<year>2006</year>). <article-title>Influence of menstrual cycle on QT interval dynamics</article-title>. <source>Pacing Clin Electrophysiol</source>
<volume>29</volume>, <fpage>607</fpage>&#x02013;<lpage>613</lpage>.<pub-id pub-id-type="pmid">16784426</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0068"><mixed-citation publication-type="journal" id="tjp12403-cit-0068">
<string-name>
<surname>Nakajo</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ulbrich</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Kubo</surname>
<given-names>Y</given-names>
</string-name> &#x00026; <string-name>
<surname>Isacoff</surname>
<given-names>EY</given-names>
</string-name> (<year>2010</year>). <article-title>Stoichiometry of the KCNQ1 &#x02013; KCNE1 ion channel complex</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>107</volume>, <fpage>18862</fpage>&#x02013;<lpage>18867</lpage>.<pub-id pub-id-type="pmid">20962273</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0069"><mixed-citation publication-type="journal" id="tjp12403-cit-0069">
<string-name>
<surname>Nakamura</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>C&#x02010;X</given-names>
</string-name>, <string-name>
<surname>Asada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Oren</surname>
<given-names>RV</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>ZI</given-names>
</string-name>, <string-name>
<surname>Clancy</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Isobe</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> (<year>2007</year>). <article-title>Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch&#x02010;clamp and computational modeling study</article-title>. <source>Circulation</source>
<volume>116</volume>, <fpage>2913</fpage>&#x02013;<lpage>2922</lpage>.<pub-id pub-id-type="pmid">18056530</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0070"><mixed-citation publication-type="journal" id="tjp12403-cit-0070">
<string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Berneche</surname>
<given-names>S</given-names>
</string-name> &#x00026; <string-name>
<surname>Roux</surname>
<given-names>B</given-names>
</string-name> (<year>2004</year>). <article-title>Control of ion selectivity in potassium channels by electrostatic and dynamic properties of carbonyl ligands</article-title>. <source>Nature</source>
<volume>431</volume>, <fpage>830</fpage>&#x02013;<lpage>834</lpage>.<pub-id pub-id-type="pmid">15483608</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0071"><mixed-citation publication-type="journal" id="tjp12403-cit-0071">
<string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> &#x00026; <string-name>
<surname>Roux</surname>
<given-names>B</given-names>
</string-name> (<year>2008</year>). <article-title>Control of ion selectivity in LeuT: Two Na<sup>+</sup> binding sites with two different mechanisms</article-title>. <source>J Mol Biol</source>
<volume>377</volume>, <fpage>804</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">18280500</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0072"><mixed-citation publication-type="journal" id="tjp12403-cit-0072">
<string-name>
<surname>O'Hara</surname>
<given-names>T</given-names>
</string-name> &#x00026; <string-name>
<surname>Rudy</surname>
<given-names>Y</given-names>
</string-name> (<year>2012</year>). <article-title>Arrhythmia formation in subclinical (&#x0201c;silent&#x0201d;) long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example</article-title>. <source>Heart Rhythm</source>
<volume>9</volume>, <fpage>275</fpage>&#x02013;<lpage>282</lpage>.<pub-id pub-id-type="pmid">21952006</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0073"><mixed-citation publication-type="journal" id="tjp12403-cit-0073">
<string-name>
<surname>O'Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Virag</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Varro</surname>
<given-names>A</given-names>
</string-name> &#x00026; <string-name>
<surname>Rudy</surname>
<given-names>Y</given-names>
</string-name> (<year>2011</year>). <article-title>Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation</article-title>. <source>PLoS Comput Biol</source>
<volume>7</volume>, <fpage>e1002061</fpage>.<pub-id pub-id-type="pmid">21637795</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0074"><mixed-citation publication-type="journal" id="tjp12403-cit-0074">
<string-name>
<surname>Pages</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Torres</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ju</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bansal</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Alewood</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Kuchel</surname>
<given-names>PW</given-names>
</string-name> &#x00026; <string-name>
<surname>Vandenberg</surname>
<given-names>JI</given-names>
</string-name> (<year>2009</year>). <article-title>Structure of the pore&#x02010;helix of the hERG K<sup>+</sup> channel</article-title>. <source>Eur Biophys J</source>
<volume>39</volume>, <fpage>111</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">19305991</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0075"><mixed-citation publication-type="journal" id="tjp12403-cit-0075">
<string-name>
<surname>Perrin</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Kuchel</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>TJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Vandenberg</surname>
<given-names>JI</given-names>
</string-name> (<year>2008</year>). <article-title>Drug binding to the inactivated state is necessary but not sufficient for high&#x02010;affinity binding to human <italic>ether&#x02010;&#x000e0;&#x02010;go&#x02010;go</italic>&#x02010;related gene channels</article-title>. <source>Mol Pharmacol</source>
<volume>74</volume>, <fpage>1443</fpage>&#x02013;<lpage>1452</lpage>.<pub-id pub-id-type="pmid">18701618</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0076"><mixed-citation publication-type="journal" id="tjp12403-cit-0076">
<string-name>
<surname>Perry</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>de Greoot</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Helliwell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Leishman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tristani&#x02010;Firouzi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sanguinetti</surname>
<given-names>MC</given-names>
</string-name> &#x00026; <string-name>
<surname>Mitcheson</surname>
<given-names>J</given-names>
</string-name> (<year>2004</year>). <article-title>Structural determinants of HERG channel block by clofilium and ibutilide</article-title>. <source>Mol Pharmacol</source>
<volume>66</volume>, <fpage>240</fpage>&#x02013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">15266014</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0077"><mixed-citation publication-type="journal" id="tjp12403-cit-0077">
<string-name>
<surname>Pham</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Danilo</surname>
<given-names>JP</given-names>
</string-name> &#x00026; <string-name>
<surname>Rosen</surname>
<given-names>MR</given-names>
</string-name> (<year>2002</year>). <article-title>Effects of gonadal steroids on gender&#x02010;related differences in transmural dispersion of L&#x02010;type calcium current</article-title>. <source>Cardiovasc Res</source>
<volume>53</volume>, <fpage>752</fpage>.<pub-id pub-id-type="pmid">11861045</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0078"><mixed-citation publication-type="journal" id="tjp12403-cit-0078">
<string-name>
<surname>Pham</surname>
<given-names>TV</given-names>
</string-name> &#x00026; <string-name>
<surname>Rosen</surname>
<given-names>MR</given-names>
</string-name> (<year>2002</year>). <article-title>Sex, hormones, and repolarization</article-title>. <source>Cardiovasc Res</source>
<volume>53</volume>, <fpage>740</fpage>&#x02013;<lpage>751</lpage>.<pub-id pub-id-type="pmid">11861044</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0079"><mixed-citation publication-type="journal" id="tjp12403-cit-0079">
<string-name>
<surname>Pham</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>Sosunov</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Gainullin</surname>
<given-names>RZ</given-names>
</string-name>, <string-name>
<surname>Danilo</surname>
<given-names>P</given-names>
<suffix>Jr</suffix>
</string-name> &#x00026; <string-name>
<surname>Rosen</surname>
<given-names>MR</given-names>
</string-name> (<year>2001</year>). <article-title>Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I<sub>K</sub>&#x02010;blocking drugs</article-title>. <source>Circulation</source>
<volume>103</volume>, <fpage>2207</fpage>&#x02013;<lpage>2212</lpage>.<pub-id pub-id-type="pmid">11331264</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0080"><mixed-citation publication-type="journal" id="tjp12403-cit-0080">
<string-name>
<surname>Phillips</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Braun</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gumbart</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tajkhorshid</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Villa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Chipot</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Skeel</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Kale</surname>
<given-names>L</given-names>
</string-name> &#x00026; <string-name>
<surname>Schulten</surname>
<given-names>K</given-names>
</string-name> (<year>2005</year>). <article-title>Scalable molecular dynamics with NAMD</article-title>. <source>J Comput Chem</source>
<volume>26</volume>, <fpage>1781</fpage>&#x02013;<lpage>1802</lpage>.<pub-id pub-id-type="pmid">16222654</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0081"><mixed-citation publication-type="journal" id="tjp12403-cit-0081">
<string-name>
<surname>Robertson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>LG</given-names>
</string-name> &#x00026; <string-name>
<surname>Roux</surname>
<given-names>B</given-names>
</string-name> (<year>2008</year>). <article-title>Long&#x02010;pore electrostatics in inward&#x02010;rectifier potassium channels</article-title>. <source>J Gen Physiol</source>
<volume>132</volume>, <fpage>613</fpage>&#x02013;<lpage>632</lpage>.<pub-id pub-id-type="pmid">19001143</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0082"><mixed-citation publication-type="journal" id="tjp12403-cit-0082">
<string-name>
<surname>Rodriguez</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kilborn</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>XK</given-names>
</string-name>, <string-name>
<surname>Pezzullo</surname>
<given-names>JC</given-names>
</string-name> &#x00026; <string-name>
<surname>Woosley</surname>
<given-names>RL</given-names>
</string-name> (<year>2001</year>). <article-title>Drug&#x02010;induced QT prolongation in women during the menstrual cycle</article-title>. <source>J Am Med Assoc</source>
<volume>285</volume>, <fpage>1322</fpage>&#x02013;<lpage>1326</lpage>.</mixed-citation></ref><ref id="tjp12403-bib-0083"><mixed-citation publication-type="journal" id="tjp12403-cit-0083">
<string-name>
<surname>Rodriguez&#x02010;Menchaca</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ferrer&#x02010;Villada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lara</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fernandez</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Navarro&#x02010;Polanco</surname>
<given-names>RA</given-names>
</string-name> &#x00026; <string-name>
<surname>Sanchez&#x02010;Chapula</surname>
<given-names>JA</given-names>
</string-name> (<year>2006</year>). <article-title>Block of HERG channels by berberine: mechanisms of voltage&#x02010; and state&#x02010;dependence probed with site&#x02010;directed mutant channels</article-title>. <source>J Cardiovasc Pharmacol</source>
<volume>47</volume>, <fpage>21</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">16424781</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0084"><mixed-citation publication-type="journal" id="tjp12403-cit-0084">
<string-name>
<surname>Romero</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Trenor</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Saiz</surname>
<given-names>J</given-names>
</string-name> &#x00026; <string-name>
<surname>Clancy</surname>
<given-names>CE</given-names>
</string-name> (<year>2014</year>). <article-title>In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome</article-title>. <source>J Mol Cell Cardiol</source>
<volume>72</volume>, <fpage>126</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">24631769</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0085"><mixed-citation publication-type="journal" id="tjp12403-cit-0085">
<string-name>
<surname>Salama</surname>
<given-names>G</given-names>
</string-name> &#x00026; <string-name>
<surname>Bett</surname>
<given-names>GC</given-names>
</string-name> (<year>2014</year>). <article-title>Sex differences in the mechanisms underlying long QT syndrome</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>307</volume>, <fpage>H640</fpage>&#x02013;<lpage>H648</lpage>.<pub-id pub-id-type="pmid">24973386</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0086"><mixed-citation publication-type="journal" id="tjp12403-cit-0086">
<string-name>
<surname>Shimoni</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Emmett</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nygren</surname>
<given-names>A</given-names>
</string-name> &#x00026; <string-name>
<surname>Kargacin</surname>
<given-names>G</given-names>
</string-name> (<year>2009</year>). <article-title>Sex&#x02010;dependent impairment of cardiac action potential conduction in type 1 diabetic rats</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>296</volume>, <fpage>H1442</fpage>&#x02013;<lpage>H1450</lpage>.<pub-id pub-id-type="pmid">19286947</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0087"><mixed-citation publication-type="journal" id="tjp12403-cit-0087">
<string-name>
<surname>Sims</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Reisenweber</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Viswanathan</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>B&#x02010;R</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>WH</given-names>
</string-name> &#x00026; <string-name>
<surname>Salama</surname>
<given-names>G</given-names>
</string-name> (<year>2008</year>). <article-title>Sex, age, and regional differences in L&#x02010;type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug&#x02010;induced long QT type 2</article-title>. <source>Circ Res</source>
<volume>102</volume>, <fpage>e86</fpage>&#x02013;<lpage>e100</lpage>.<pub-id pub-id-type="pmid">18436794</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0088"><mixed-citation publication-type="journal" id="tjp12403-cit-0088">
<string-name>
<surname>Smetana</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Batchvarov</surname>
<given-names>VN</given-names>
</string-name>, <string-name>
<surname>Hnatkova</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Camm</surname>
<given-names>AJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Malik</surname>
<given-names>M</given-names>
</string-name> (<year>2002</year>). <article-title>Sex differences in repolarization homogeneity and its circadian pattern</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>282</volume>, <fpage>H1889</fpage>&#x02013;<lpage>H1897</lpage>.<pub-id pub-id-type="pmid">11959656</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0089"><mixed-citation publication-type="journal" id="tjp12403-cit-0089">
<string-name>
<surname>Stansfeld</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Gedeck</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gosling</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mitcheson</surname>
<given-names>JS</given-names>
</string-name> &#x00026; <string-name>
<surname>Sutcliffe</surname>
<given-names>MJ</given-names>
</string-name> (<year>2007</year>). <article-title>Drug block of the hERG potassium channel: Insight from modeling</article-title>. <source>Proteins</source>
<volume>68</volume>, <fpage>568</fpage>&#x02013;<lpage>580</lpage>.<pub-id pub-id-type="pmid">17444521</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0090"><mixed-citation publication-type="journal" id="tjp12403-cit-0090">
<string-name>
<surname>Stary</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wacker</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Boukharta</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zachariae</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Karimi&#x02010;Nejad</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Aqvist</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vriend</surname>
<given-names>G</given-names>
</string-name> &#x00026; <string-name>
<surname>de Groot</surname>
<given-names>BL</given-names>
</string-name> (<year>2010</year>). <article-title>Toward a consensus model of the HERG potassium channel</article-title>. <source>ChemMedChem</source>
<volume>5</volume>, <fpage>455</fpage>&#x02013;<lpage>467</lpage>.<pub-id pub-id-type="pmid">20104563</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0091"><mixed-citation publication-type="journal" id="tjp12403-cit-0091">
<string-name>
<surname>Stork</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Timin</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Berjukow</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huber</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hohaus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Auer</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Hering</surname>
<given-names>S</given-names>
</string-name> (<year>2007</year>). <article-title>State dependent dissociation of HERG channel inhibitors</article-title>. <source>Br J Pharmacol</source>
<volume>151</volume>, <fpage>1368</fpage>&#x02013;<lpage>1376</lpage>.<pub-id pub-id-type="pmid">17592502</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0092"><mixed-citation publication-type="journal" id="tjp12403-cit-0092">
<string-name>
<surname>Stramba&#x02010;Badiale</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Locati</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Martinelli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Courville</surname>
<given-names>J</given-names>
</string-name> &#x00026; <string-name>
<surname>Schwartz</surname>
<given-names>PJ</given-names>
</string-name> (<year>1997</year>). <article-title>Gender and the relationship between ventricular repolarization and cardiac cycle length during 24&#x02010;h Holter recordings</article-title>. <source>Eur Heart J</source>
<volume>18</volume>, <fpage>1000</fpage>&#x02013;<lpage>1006</lpage>.<pub-id pub-id-type="pmid">9183593</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0093"><mixed-citation publication-type="journal" id="tjp12403-cit-0093">
<string-name>
<surname>Tadros</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ton</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Fiset</surname>
<given-names>C</given-names>
</string-name> &#x00026; <string-name>
<surname>Nattel</surname>
<given-names>S</given-names>
</string-name> (<year>2014</year>). <article-title>Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms</article-title>. <source>Can J Cardiol</source>
<volume>30</volume>, <fpage>783</fpage>&#x02013;<lpage>792</lpage>.<pub-id pub-id-type="pmid">24970790</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0094"><mixed-citation publication-type="journal" id="tjp12403-cit-0094">
<string-name>
<surname>Thompson</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Higgins</surname>
<given-names>DG</given-names>
</string-name> &#x00026; <string-name>
<surname>Gibson</surname>
<given-names>TJ</given-names>
</string-name> (<year>1994</year>). <article-title>CLUSTAL&#x02010;W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position&#x02010;specific gap penalties and weight matrix choice</article-title>. <source>Nucleic Acids Res</source>
<volume>22</volume>, <fpage>4673</fpage>&#x02013;<lpage>4680</lpage>.<pub-id pub-id-type="pmid">7984417</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0095"><mixed-citation publication-type="journal" id="tjp12403-cit-0095">
<string-name>
<surname>Vandenberg</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>BD</given-names>
</string-name> &#x00026; <string-name>
<surname>Campbell</surname>
<given-names>TJ</given-names>
</string-name> (<year>2001</year>). <article-title>HERG K<sup>+</sup> channels: friend and foe</article-title>. <source>Trends Pharmacol Sci</source>
<volume>22</volume>, <fpage>240</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">11339975</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0096"><mixed-citation publication-type="journal" id="tjp12403-cit-0096">
<string-name>
<surname>Van Opstal</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Leunissen</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Wellens</surname>
<given-names>HJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Vos</surname>
<given-names>MA</given-names>
</string-name> (<year>2001</year>). <article-title>Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias</article-title>. <source>Eur J Pharmacol</source>
<volume>412</volume>, <fpage>67</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">11166738</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0097"><mixed-citation publication-type="journal" id="tjp12403-cit-0097">
<string-name>
<surname>Vaseghi</surname>
<given-names>M</given-names>
</string-name> &#x00026; <string-name>
<surname>Shivkumar</surname>
<given-names>K</given-names>
</string-name> (<year>2008</year>). <article-title>The role of the autonomic nervous system in sudden cardiac death</article-title>. <source>Prog Cardiovasc Dis</source>
<volume>50</volume>, <fpage>404</fpage>&#x02013;<lpage>419</lpage>.<pub-id pub-id-type="pmid">18474284</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0098"><mixed-citation publication-type="journal" id="tjp12403-cit-0098">
<string-name>
<surname>Wang</surname>
<given-names>YB</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Perissinotti</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Lees&#x02010;Miller</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>GQ</given-names>
</string-name>, <string-name>
<surname>Durdagi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Duff</surname>
<given-names>HJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Noskov</surname>
<given-names>SY</given-names>
</string-name> (<year>2016</year>). <article-title>Role of the pH in state&#x02010;dependent blockade of hERG currents</article-title>. <source>Sci Rep</source>
<volume>6</volume>, <fpage>32536</fpage>.<pub-id pub-id-type="pmid">27731415</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0099"><mixed-citation publication-type="journal" id="tjp12403-cit-0099">
<string-name>
<surname>Whicher</surname>
<given-names>JR</given-names>
</string-name> &#x00026; <string-name>
<surname>MacKinnon</surname>
<given-names>R</given-names>
</string-name> (<year>2016</year>). <article-title>Structure of the voltage&#x02010;gated K<sup>+</sup> channel Eag1 reveals an alternative voltage sensing mechanism</article-title>. <source>Science</source>
<volume>353</volume>, <fpage>664</fpage>&#x02013;<lpage>669</lpage>.<pub-id pub-id-type="pmid">27516594</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0100"><mixed-citation publication-type="journal" id="tjp12403-cit-0100">
<string-name>
<surname>Wilde</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Jongbloed</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Doevendans</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Duren</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Hauer</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>van Langen</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>van Tintelen</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Smeets</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>H</given-names>
</string-name> &#x00026; <string-name>
<surname>Geelen</surname>
<given-names>JL</given-names>
</string-name> (<year>1999</year>). <article-title>Auditory stimuli as a trigger for arrhythmic events differentiate HERG&#x02010;related (LQTS2) patients from KVLQT1&#x02010;related patients (LQTS1)</article-title>. <source>J Am Coll Cardiol</source>
<volume>33</volume>, <fpage>327</fpage>&#x02013;<lpage>332</lpage>.<pub-id pub-id-type="pmid">9973011</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0101"><mixed-citation publication-type="journal" id="tjp12403-cit-0101">
<string-name>
<surname>Xie</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Garfinkel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>Z</given-names>
</string-name> &#x00026; <string-name>
<surname>Weiss</surname>
<given-names>JN</given-names>
</string-name> (<year>2010</year>). <article-title>So little source, so much sink: requirements for afterdepolarizations to propagate in tissue</article-title>. <source>Biophys J</source>
<volume>99</volume>, <fpage>1408</fpage>&#x02013;<lpage>1415</lpage>.<pub-id pub-id-type="pmid">20816052</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0102"><mixed-citation publication-type="journal" id="tjp12403-cit-0102">
<string-name>
<surname>Yang</surname>
<given-names>PC</given-names>
</string-name> &#x00026; <string-name>
<surname>Clancy</surname>
<given-names>CE</given-names>
</string-name> (<year>2012</year>). <article-title>In silico prediction of sex&#x02010;based differences in human susceptibility to cardiac ventricular tachyarrhythmias</article-title>. <source>Front Physiol</source>
<volume>3</volume>, <fpage>360</fpage>.<pub-id pub-id-type="pmid">23049511</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0103"><mixed-citation publication-type="journal" id="tjp12403-cit-0103">
<string-name>
<surname>Yang</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Kurokawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name> &#x00026; <string-name>
<surname>Clancy</surname>
<given-names>CE</given-names>
</string-name> (<year>2010</year>). <article-title>Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study</article-title>. <source>PLoS Comput Biol</source>
<volume>6</volume>, <fpage>e1000658</fpage>.<pub-id pub-id-type="pmid">20126530</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0104"><mixed-citation publication-type="journal" id="tjp12403-cit-0104">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Papp</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Defranco</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>F</given-names>
</string-name> &#x00026; <string-name>
<surname>Salama</surname>
<given-names>G</given-names>
</string-name> (<year>2012</year>). <article-title>Oestrogen upregulates L&#x02010;type Ca&#x000b2;&#x0207a; channels via oestrogen&#x02010;receptor&#x02010;&#x003b1; by a regional genomic mechanism in female rabbit hearts</article-title>. <source>J Physiol</source>
<volume>590</volume>, <fpage>493</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">22124151</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0105"><mixed-citation publication-type="journal" id="tjp12403-cit-0105">
<string-name>
<surname>Yesselman</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>JL</given-names>
</string-name> &#x00026; <string-name>
<surname>Brooks</surname>
<given-names>CL</given-names>
</string-name> (<year>2012</year>). <article-title>MATCH: an atom&#x02010;typing toolset for molecular mechanics force fields</article-title>. <source>J Comput Chem</source>
<volume>33</volume>, <fpage>189</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="pmid">22042689</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0106"><mixed-citation publication-type="journal" id="tjp12403-cit-0106">
<string-name>
<surname>Young</surname>
<given-names>RJ</given-names>
</string-name> &#x00026; <string-name>
<surname>Panfilov</surname>
<given-names>AV</given-names>
</string-name> (<year>2010</year>). <article-title>Anisotropy of wave propagation in the heart can be modeled by a Riemannian electrophysiological metric</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>107</volume>, <fpage>15063</fpage>&#x02013;<lpage>15068</lpage>.<pub-id pub-id-type="pmid">20696934</pub-id></mixed-citation></ref><ref id="tjp12403-bib-0107"><mixed-citation publication-type="journal" id="tjp12403-cit-0107">
<string-name>
<surname>Zachariae</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Giordanetto</surname>
<given-names>F</given-names>
</string-name> &#x00026; <string-name>
<surname>Leach</surname>
<given-names>AG</given-names>
</string-name> (<year>2009</year>). <article-title>Side chain flexibilities in the human ether&#x02010;a&#x02010;go&#x02010;go related gene potassium channel (hERG) together with matched&#x02010;pair binding studies suggest a new binding mode for channel blockers</article-title>. <source>J Med Chem</source>
<volume>52</volume>, <fpage>4266</fpage>&#x02013;<lpage>4276</lpage>.<pub-id pub-id-type="pmid">19534531</pub-id></mixed-citation></ref></ref-list><app-group><app id="tjp12403-app-0001" content-type="Appendix"><title>Simulation of genomic sex steroid hormone effects</title><sec id="tjp12403-sec-0300"><p>Female hearts had reduced expression of the K(C)&#x02010;channel subunits HERG, minK, Kir2.3, Kv1.4, KChIP2, SUR2, and Kir6.2, and lower mRNA expression of connexin43 and phospho&#x02010;lamban compared to males. Experiments demonstrated concurrence of changes between gene and protein expression for HERG, minK, Kv1.4, KChIP2, IRX5, Nav1.5 and connexin43 (Nav1.5&#x02010;expression showed no male&#x02013;female differences) (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0030" ref-type="ref">2010</xref>). Details are given in Table <xref rid="tjp12403-tbl-0006" ref-type="table-wrap">A1</xref>.</p><table-wrap id="tjp12403-tbl-0006" xml:lang="en" orientation="portrait" position="anchor"><label>Table A1</label><caption><p>Sex&#x02010;based differences in ion channel subunit expression from non&#x02010;diseased ventricles used in the computational model</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" valign="bottom" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Epi</th><th align="center" valign="bottom" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Endo</th></tr><tr style="border-bottom:solid 1px #000000"><th valign="bottom" align="left" rowspan="1" colspan="1">Channels in the model</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="center" valign="bottom" rowspan="1" colspan="1">Male</th><th align="center" valign="bottom" rowspan="1" colspan="1">Female</th><th align="center" valign="bottom" rowspan="1" colspan="1">Male</th><th align="center" valign="bottom" rowspan="1" colspan="1">Female</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>Ks</sub>
</td><td align="left" rowspan="1" colspan="1">KvLQT1</td><td align="center" rowspan="1" colspan="1">104.2</td><td align="center" rowspan="1" colspan="1">77.5</td><td align="center" rowspan="1" colspan="1">90.4</td><td align="center" rowspan="1" colspan="1">109.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
MinK<break/>
(KCNE1)</td><td align="center" rowspan="1" colspan="1">
13.6&#x000a0;&#x000b1;&#x000a0;1.4<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02191;</td><td align="center" rowspan="1" colspan="1">
7.3&#x000a0;&#x000b1;&#x000a0;5<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02193;</td><td align="center" rowspan="1" colspan="1">
11.9&#x000a0;&#x000b1;&#x000a0;4.2<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref>&#x02191;</td><td align="center" rowspan="1" colspan="1">
5.8&#x000a0;&#x000b1;&#x000a0;2.6<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref>&#x02193;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">1.04&#x000a0;&#x000b1;&#x000a0;0.04</td><td align="center" rowspan="1" colspan="1">0.87&#x000a0;&#x000b1;&#x000a0;0.14</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.12</td><td align="center" rowspan="1" colspan="1">0.83&#x000a0;&#x000b1;&#x000a0;0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Functions</td><td align="left" colspan="4" rowspan="1">Co&#x02010;expression of KvLQT1 and MinK shifts the voltage to more positive voltages. Also it increases amplitude of expressed current. Only MinK shows significant differences between male and female. The stoichiometry of KCNE1:KCNQ1 in <italic>I</italic>
<sub>Ks</sub> channels is a fixed 2:4 (Nakajo <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0068" ref-type="ref">2010</xref>). The ratio was calculated by modified the 1/3 of current activity depending on MinK.</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>Kr</sub>
</td><td align="left" rowspan="1" colspan="1">
hERG<break/>
(Kv11.1)</td><td align="center" rowspan="1" colspan="1">
179.5&#x000a0;&#x000b1;&#x000a0;6.4<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02191;</td><td align="center" rowspan="1" colspan="1">
144.2&#x000a0;&#x000b1;&#x000a0;41.1<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02193;
</td><td align="center" rowspan="1" colspan="1">
164.8&#x000a0;&#x000b1;&#x000a0;54.9<break/>
&#x02191;
</td><td align="center" rowspan="1" colspan="1">
130.5&#x000a0;&#x000b1;&#x000a0;65<break/>
&#x02193;
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">1.09&#x000a0;&#x000b1;&#x000a0;0.039</td><td align="center" rowspan="1" colspan="1">0.875&#x000a0;&#x000b1;&#x000a0;0.25</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.33</td><td align="center" rowspan="1" colspan="1">0.79&#x000a0;&#x000b1;&#x000a0;0.39</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>K1</sub>
</td><td align="left" rowspan="1" colspan="1">Kir2.1</td><td align="center" rowspan="1" colspan="1">94.5</td><td align="center" rowspan="1" colspan="1">93.8</td><td align="center" rowspan="1" colspan="1">104.1</td><td align="center" rowspan="1" colspan="1">79.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Kir2.2</td><td align="center" rowspan="1" colspan="1">111.1</td><td align="center" rowspan="1" colspan="1">115.3</td><td align="center" rowspan="1" colspan="1">93.6</td><td align="center" rowspan="1" colspan="1">104.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Kir2.3</td><td align="center" rowspan="1" colspan="1">
91.2&#x000a0;&#x000b1;&#x000a0;31.8<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02191;
</td><td align="center" rowspan="1" colspan="1">
21.4&#x000a0;&#x000b1;&#x000a0;10.6<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02193;</td><td align="center" rowspan="1" colspan="1">
92.7&#x000a0;&#x000b1;&#x000a0;26.8<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref>&#x02191;</td><td align="center" rowspan="1" colspan="1">
55.2&#x000a0;&#x000b1;&#x000a0;21.5<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref>&#x02193;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">0.98&#x000a0;&#x000b1;&#x000a0;0.12</td><td align="center" rowspan="1" colspan="1">0.74&#x000a0;&#x000b1;&#x000a0;0.04</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.09</td><td align="center" rowspan="1" colspan="1">0.86&#x000a0;&#x000b1;&#x000a0;0.077</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Functions</td><td align="left" colspan="4" rowspan="1">Kir2.x channels mediate cardiac <italic>I</italic>
<sub>K1</sub> (Dhamoon <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0015" ref-type="ref">2004</xref>); however, only Kir2.3 is significantly different. The ratio was calculated by changing the 1/3 of Kir2.3 channel activity.</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>to,s</sub>
</td><td align="left" rowspan="1" colspan="1">Kv1.4</td><td align="center" rowspan="1" colspan="1">
12.1&#x000a0;&#x000b1;&#x000a0;3.3<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02191;
</td><td align="center" rowspan="1" colspan="1">
5.4&#x000a0;&#x000b1;&#x000a0;3.8<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
20.2&#x000a0;&#x000b1;&#x000a0;4.0<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
12.9&#x000a0;&#x000b1;&#x000a0;5.2<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref> &#x02193;
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">0.6&#x000a0;&#x000b1;&#x000a0;0.16</td><td align="center" rowspan="1" colspan="1">0.26&#x000a0;&#x000b1;&#x000a0;0.19</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">0.64&#x000a0;&#x000b1;&#x000a0;0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>NaK</sub>
</td><td align="left" rowspan="1" colspan="1">
ATPase<break/>
a1
</td><td align="center" rowspan="1" colspan="1">
207.7&#x000a0;&#x000b1;&#x000a0;67<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;</td><td align="center" rowspan="1" colspan="1">
513.4&#x000a0;&#x000b1;&#x000a0;134.6<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
269.0&#x000a0;&#x000b1;&#x000a0;70.3<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
622.5&#x000a0;&#x000b1;&#x000a0;287.7<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref> &#x02191;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">a3</td><td align="center" rowspan="1" colspan="1">
1481&#x000a0;&#x000b1;&#x000a0;267<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
917.8&#x000a0;&#x000b1;&#x000a0;416.7<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref>&#x02193;
</td><td align="center" rowspan="1" colspan="1">
1547.6&#x000a0;&#x000b1;&#x000a0;299.5<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref>&#x02191;
</td><td align="center" rowspan="1" colspan="1">
1014.2&#x000a0;&#x000b1;&#x000a0;294.5<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref> &#x02193;
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">0.94&#x000a0;&#x000b1;&#x000a0;0.18</td><td align="center" rowspan="1" colspan="1">0.7&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="center" rowspan="1" colspan="1">1.0&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">0.79&#x000a0;&#x000b1;&#x000a0;0.26</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Functions</td><td align="left" colspan="4" rowspan="1">a3 is about 2&#x02010;fold more active than a1 in LV (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0029" ref-type="ref">2007</xref>). The ratio was calculated depending on 1/3 of a1 and 2/3 of a3.</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>pCa</sub>
</td><td align="left" rowspan="1" colspan="1">PMCA1</td><td align="center" rowspan="1" colspan="1">31.7</td><td align="center" rowspan="1" colspan="1">46.4</td><td align="center" rowspan="1" colspan="1">44.1</td><td align="center" rowspan="1" colspan="1">48.1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMCA4</td><td align="center" rowspan="1" colspan="1">
377.0&#x000a0;&#x000b1;&#x000a0;57.2<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
682.1&#x000a0;&#x000b1;&#x000a0;265.9<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
426.8&#x000a0;&#x000b1;&#x000a0;116.6<break/>
m&#x02193;
</td><td align="center" rowspan="1" colspan="1">
685.2&#x000a0;&#x000b1;&#x000a0;379.7<break/>
f&#x02191;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">0.88&#x000a0;&#x000b1;&#x000a0;0.13</td><td align="center" rowspan="1" colspan="1">1.6&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="center" rowspan="1" colspan="1">1.&#x000b1; 0.27</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1; 0.89</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Functions</td><td align="left" colspan="4" rowspan="1">PMCA1 serves a critical housekeeping function that is required for the maintenance of basic cellular function (Brini, <xref rid="tjp12403-bib-0009" ref-type="ref">2009</xref>). PMCA4 nearly ubiquitous distribution has a similar role to that of PMCA1. PMCA4 was reported much more activity than PMCA1 in LV (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0029" ref-type="ref">2007</xref>), and there are no differences between sexes in PMCA1. The ratio was calculated depended only on the PMCA4.</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>up</sub>
</td><td align="left" rowspan="1" colspan="1">SERCA2</td><td align="center" rowspan="1" colspan="1">
4850.5&#x000a0;&#x000b1;&#x000a0;146<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
6728.4&#x000a0;&#x000b1;&#x000a0;1876.1<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;</td><td align="center" rowspan="1" colspan="1">
3410.4&#x000a0;&#x000b1;&#x000a0;982.1<break/>
m</td><td align="center" rowspan="1" colspan="1">
3921.9&#x000a0;&#x000b1;&#x000a0;1760.7<break/>
f
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">1.42&#x000a0;&#x000b1;&#x000a0;0.04</td><td align="center" rowspan="1" colspan="1">1.97&#x000a0;&#x000b1;&#x000a0;0.55</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.28</td><td align="center" rowspan="1" colspan="1">1.15&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Calmodulin</td><td align="left" rowspan="1" colspan="1">CALM1</td><td align="center" rowspan="1" colspan="1">1329.5</td><td align="center" rowspan="1" colspan="1">991.9</td><td align="center" rowspan="1" colspan="1">879.8</td><td align="center" rowspan="1" colspan="1">1122.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CALM3</td><td align="center" rowspan="1" colspan="1">
1326.9&#x000a0;&#x000b1;&#x000a0;220<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
1955.5&#x000a0;&#x000b1;&#x000a0;372.2<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;</td><td align="center" rowspan="1" colspan="1">
1206.9&#x000a0;&#x000b1;&#x000a0;187.7<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">
<sup>**</sup>
</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
1600.5&#x000a0;&#x000b1;&#x000a0;242.9<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref> &#x02191;
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">1.07&#x000a0;&#x000b1;&#x000a0;0.12</td><td align="center" rowspan="1" colspan="1">1.41&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">1&#x000a0;&#x000b1;&#x000a0;0.1</td><td align="center" rowspan="1" colspan="1">1.21&#x000a0;&#x000b1;&#x000a0;0.14</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Functions</td><td align="left" colspan="4" rowspan="1">CALM3 is more activity than CALM1 (&#x0223c;2&#x02010;fold in LV) (Gaborit <italic>et&#x000a0;al</italic>. <xref rid="tjp12403-bib-0029" ref-type="ref">2007</xref>). The ratio was obtained by changing the 2/3 of activity depends on CALM3.</td></tr><tr><td align="left" rowspan="1" colspan="1">Gap&#x02010;junction</td><td align="left" rowspan="1" colspan="1">Cx43</td><td align="center" rowspan="1" colspan="1">
1124.1&#x000a0;&#x000b1;&#x000a0;357<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
728.6&#x000a0;&#x000b1;&#x000a0;274.1<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">*</xref> &#x02193;
</td><td align="center" rowspan="1" colspan="1">
1196.3&#x000a0;&#x000b1;&#x000a0;311.7<break/>
m<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref> &#x02191;
</td><td align="center" rowspan="1" colspan="1">
810.9&#x000a0;&#x000b1;&#x000a0;333.9<break/>
f<xref ref-type="fn" rid="tjp12403-tbl6-note-0001">**</xref> &#x02193;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ratio</td><td align="center" rowspan="1" colspan="1">0.94&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="center" rowspan="1" colspan="1">0.61&#x000a0;&#x000b1;&#x000a0;0.24</td><td align="center" rowspan="1" colspan="1">1.0&#x000a0;&#x000b1;&#x000a0;0.26</td><td align="center" rowspan="1" colspan="1">0.68&#x000a0;&#x000b1;&#x000a0;0.28</td></tr></tbody></table><table-wrap-foot><fn id="tjp12403-tbl6-note-0001"><p>Ratios are relative to the male endocardial cell as we published previously (Yang &#x00026; Clancy, <xref rid="tjp12403-bib-0102" ref-type="ref">2012</xref>). <sup>*</sup>Differences between male and female in Epi is statistically significant. <sup>**</sup>Differences between male and female in Endo are statistically significant.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap id="tjp12403-tbl-0007" xml:lang="en" orientation="portrait" position="anchor"><label>Table A2</label><caption><p>Simulated effects of progesterone on <italic>I</italic>
<sub>Ks</sub> and <italic>I</italic>
<sub>Ca,L</sub>
</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Channel</th><th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Progesterone (baseline)</th><th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Progesterone (SNS stimulations)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">2.5&#x000a0;n<sc>m</sc>
</td><td align="char" rowspan="1" colspan="1">40.6&#x000a0;n<sc>m</sc>
</td><td align="center" rowspan="1" colspan="1">2.5&#x000a0;n<sc>m</sc>
</td><td align="center" rowspan="1" colspan="1">40.6&#x000a0;n<sc>m</sc>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>Ks</sub>
</td><td align="char" rowspan="1" colspan="1">1.19</td><td align="char" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">3.488</td><td align="center" rowspan="1" colspan="1">3.52</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sub>CaL</sub>
</td><td align="char" rowspan="1" colspan="1">1.0</td><td align="char" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Kinetics of <italic>I</italic>
<sub>CaL</sub>
</td><td colspan="2" align="center" rowspan="1">No effects</td><td align="center" rowspan="1" colspan="1">
<italic>d</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(&#x02212;(<italic>v</italic>&#x000a0;+ 3.94&#x000a0;+&#x000a0;16&#x000a0;&#x02212;&#x000a0;1.5))/4.73]}<break/>
<italic>f</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(<italic>v</italic>&#x000a0;+&#x000a0;19.58&#x000a0;+ 8.0&#x000a0;+&#x000a0;1.7)/3.596]}
</td><td align="center" rowspan="1" colspan="1">
<italic>d</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(&#x02212;(<italic>v</italic>&#x000a0;+&#x000a0;3.94&#x000a0;+ 16&#x02212;4.4))/5.23]}<break/>
<italic>f</italic>
<sub>ss</sub>&#x000a0;=&#x000a0;1.0/{1.0&#x000a0;+&#x000a0;exp[(<italic>v</italic>&#x000a0;+&#x000a0;19.58&#x000a0;+ 8.0&#x000a0;+&#x000a0;3.7)/3.096]}</td></tr><tr><td align="left" rowspan="1" colspan="1">Reference</td><td colspan="2" align="left" rowspan="1">Nakamura <italic>et&#x000a0;al</italic>. (<xref rid="tjp12403-bib-0069" ref-type="ref">2007</xref>)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0011" orientation="portrait" position="anchor"><label>Figure A1</label><caption><title>Single cell action potentials during simulated arousal via sympathetic stimulation in the setting of control or the G604S mutation</title><p>Action potentials are shown following pacing for 400 paced beats at a cycle length of 1000&#x000a0;ms in single simulated endocardial cells. The 399th and 400th paced beats are shown, after the pacing frequency was increased to 800&#x000a0;ms with or without SNS applied. <italic>A</italic>, control case with no SNS applications. <italic>B</italic>, dofetilide with no SNS applications. <italic>C</italic>, G604S mutation with no SNS applications. <italic>D</italic>, control case with SNS applied after 400&#x000a0;beats.</p></caption><graphic id="nlm-graphic-21" xlink:href="TJP-595-4695-g011"/></fig><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0012" orientation="portrait" position="anchor"><label>Figure A2</label><caption><title>Human cardiac electrophysiology predicted in female late follicular phase (no mutation) transmural tissue models and simulated pseudo&#x02010;ECGs during SNS</title><p>
<italic>A</italic>, simulated 1&#x02010;dimensional action potentials (APs) are shown following pacing for 400&#x000a0;beats at 1200&#x000a0;ms pacing frequency. The 398th&#x02013;400th paced beats are shown prior to application of SNS. Upon SNS application, the pacing frequency was increased to 800&#x000a0;ms. The pseudo ECG is shown beneath the tissue simulation. Time is shown on the <italic>x</italic>&#x02010;axis and voltage on the <italic>z</italic>&#x02010;axis. <italic>B</italic>, simulated combined effects of oestradiol and progesterone on female (no mutation) 2&#x02010;dimensional tissues during the late follicular phase of the menstrual cycle.</p></caption><graphic id="nlm-graphic-23" xlink:href="TJP-595-4695-g012"/></fig><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0013" orientation="portrait" position="anchor"><label>Figure A3</label><caption><title>The L&#x02010;type Ca<sup>2+</sup> window current</title><p>Steady&#x02010;state activation (<italic>d</italic>
<sub>ss</sub>) and steady&#x02010;state inactivation (<italic>f</italic>
<sub>ss</sub>) show the <italic>I</italic>
<sub>CaL</sub> window current during SNS via ISO. <italic>A</italic>, DHT 35&#x000a0;n<sc>m</sc> (blue lines) indicated a smaller window current compared to progesterone 2.5&#x000a0;n<sc>m</sc> (red lines). <italic>B</italic>, high concentration of progesterone (40.6&#x000a0;n<sc>m</sc>, red lines) reduced the <italic>I</italic>
<sub>CaL</sub> window current.</p></caption><graphic id="nlm-graphic-25" xlink:href="TJP-595-4695-g013"/></fig><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0014" orientation="portrait" position="anchor"><label>Figure A4</label><caption><title>Ionic mechanisms of simulated arousal via sympathetic stimulation in the setting of the G604S mutation causing inherited LQT2 syndrome</title><p>
<italic>A</italic>, cellular APs. <italic>B</italic>, intracellular Ca<sup>2+</sup> concentration. <italic>C</italic>, L&#x02010;type Ca<sup>2+</sup> current. <italic>D</italic>, Na<sup>+</sup> current. <italic>E</italic>, Na<sup>+</sup>/Ca<sup>2+</sup> exchange current. <italic>F</italic>, Na<sup>+</sup>/K<sup>+</sup>&#x02010;ATPase (NKA). Same pacing protocol was used as in Fig.&#x000a0;<xref rid="tjp12403-fig-0002" ref-type="fig">2</xref>. The 399th&#x02013;400th paced beats (red arrows) are shown prior to application of SNS. Upon SNS application, the pacing frequency was increased to 800&#x000a0;ms for 100&#x000a0;beats. <italic>C</italic> shows the peak of <italic>I</italic>
<sub>CaL</sub> was lower in luteal phase or with DHT 35&#x000a0;n<sc>m</sc>.</p></caption><graphic id="nlm-graphic-27" xlink:href="TJP-595-4695-g014"/></fig><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0015" orientation="portrait" position="anchor"><label>Figure A5</label><caption><title>RMS fluctuations per residue (550&#x02013;670) for all the subunits of WT (thick grey line) and G604S (thick red line), E2 bound to WT chain C (black circles) and E2 bound to G604S chain C (red squares)</title><p>&#x000a0;</p></caption><graphic id="nlm-graphic-29" xlink:href="TJP-595-4695-g015"/></fig><fig fig-type="Figure" xml:lang="en" id="tjp12403-fig-0016" orientation="portrait" position="anchor"><label>Figure A6</label><caption><title>Action potential voltage clamp of simulated arousal via sympathetic stimulation in the setting of the G604S mutation causing inherited LQT2 Syndrome</title><p>
<italic>A</italic>, cellular action potentials were clamped to the voltages shown in Fig. A4. <italic>B</italic>, L&#x02010;type Ca<sup>2+</sup> current. <italic>C</italic>, intracellular Ca<sup>2+</sup> concentration was clamped to the diastolic rest concentration. Same pacing protocol was used as in Fig. A4. When Ca<sup>2+</sup>&#x02010;dependent inactivation is reduced (Ca<sup>2+</sup> concentration clamped to diastolic level), with an EAD voltage clamp protocol, the Ca<sup>2+</sup> current is even larger, suggesting a strong effect of ISO that is usually tempered by Ca<sup>2+</sup>&#x02010;dependent inactivation. In the absence of ISO, the effect is much smaller (right panels).</p></caption><graphic id="nlm-graphic-31" xlink:href="TJP-595-4695-g016"/></fig></sec></app></app-group></back></article>